US20070258044A1 - Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations - Google Patents

Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations Download PDF

Info

Publication number
US20070258044A1
US20070258044A1 US11/742,996 US74299607A US2007258044A1 US 20070258044 A1 US20070258044 A1 US 20070258044A1 US 74299607 A US74299607 A US 74299607A US 2007258044 A1 US2007258044 A1 US 2007258044A1
Authority
US
United States
Prior art keywords
lens
cornea
spherical aberration
corneal
aberration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/742,996
Inventor
Sverker Norrby
Pablo Artal
Patricia Piers
Marrie Mooren
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johnson and Johnson Surgical Vision Inc
Original Assignee
Advanced Medical Optics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0001925A external-priority patent/SE0001925D0/en
Priority claimed from SE0004830A external-priority patent/SE0004830D0/en
Application filed by Advanced Medical Optics Inc filed Critical Advanced Medical Optics Inc
Priority to US11/742,996 priority Critical patent/US20070258044A1/en
Assigned to BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT reassignment BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT INTELLECTUAL PROPERTY SECURITY AGREEMENT Assignors: ADVANCED MEDICAL OPTICS, INC.
Publication of US20070258044A1 publication Critical patent/US20070258044A1/en
Assigned to ADVANCED MEDICAL OPTICS, INC. reassignment ADVANCED MEDICAL OPTICS, INC. RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: BANK OF AMERICA, N.A. AS ADMINISTRATIVE AGENT
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B3/00Apparatus for testing the eyes; Instruments for examining the eyes
    • A61B3/0016Operational features thereof
    • A61B3/0025Operational features thereof characterised by electronic signal processing, e.g. eye models
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/14Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • A61F2/16Intraocular lenses
    • A61F2/1613Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/14Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • A61F2/16Intraocular lenses
    • A61F2/1613Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus
    • A61F2/1637Correcting aberrations caused by inhomogeneities; correcting intrinsic aberrations, e.g. of the cornea, of the surface of the natural lens, aspheric, cylindrical, toric lenses
    • GPHYSICS
    • G02OPTICS
    • G02CSPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C7/00Optical parts
    • G02C7/02Lenses; Lens systems ; Methods of designing lenses
    • GPHYSICS
    • G02OPTICS
    • G02CSPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C7/00Optical parts
    • G02C7/02Lenses; Lens systems ; Methods of designing lenses
    • G02C7/024Methods of designing ophthalmic lenses
    • G02C7/028Special mathematical design techniques
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2240/00Manufacturing or designing of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2240/001Designing or manufacturing processes
    • A61F2240/002Designing or making customized prostheses
    • GPHYSICS
    • G02OPTICS
    • G02CSPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C2202/00Generic optical aspects applicable to one or more of the subgroups of G02C7/00
    • G02C2202/06Special ophthalmologic or optometric aspects
    • GPHYSICS
    • G02OPTICS
    • G02CSPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C2202/00Generic optical aspects applicable to one or more of the subgroups of G02C7/00
    • G02C2202/22Correction of higher order and chromatic aberrations, wave front measurement and calculation

Definitions

  • the present invention relates to methods of designing ophthalmic lenses that provide the eye with reduced aberrations, as well as lenses capable of providing such-visual improvements.
  • U.S. Pat. No. 5,777,719 discloses a method and an apparatus for accurately measuring higher order aberrations of the eye as an optical system with wavefront analysis.
  • a Hartmann-Shack wavefront sensor By using a Hartmann-Shack wavefront sensor, it is possible to measure higher order aberrations of the eye and use such data to find compensation for these aberrations and thereby obtain sufficient information for the design of an optical lens, which can provide a highly improved optical performance.
  • the Hartmann-Shack sensor provides means for analyzing light reflected from a point on the retina of the eye of a subject. The wavefront in the plane of the pupil is recreated in the plane of the lenslet array of the Hartmann-Shack sensor.
  • Each lenslet in the array is used to form an aerial image of the retinal point source on a CCD camera located at the focal plane of the array.
  • the wave aberration of the eye in the form resulting from a point source produced on the retina by a laser beam, displaces each spot by an amount proportional to the local slope of the wavefront at each of the lenslets.
  • the output from the CCD camera is sent to a computer, which then performs calculations to fit slope data to the first derivatives of 66 Zernike polynomials. From these calculations, coefficients for weighting the Zernike polynomials are obtained.
  • the sum of the weighted Zernike polynomials represents a reconstructed wavefront distorted by the aberrations of the eye as an optical system.
  • the individual Zemike polynomial terms will then represent different modes of aberration.
  • U.S. Pat. No. 5,050,981 discloses another method for designing a lens by calculating modulation transfer functions from tracing a large number of rays through the lens-eye system and evaluating the distribution density of the rays in the image position. This is repeatedly performed by varying at least one lens surface until a lens is found which results in a sharp focus and a maximum modulation transfer function.
  • U.S. Pat. No. 6,224,211 (Gordon) describes a method of improving the visual acuity of the human eye by successively fitting aspheric lenses to the cornea and thereby finding a lens that can reduce spherical aberration of the whole individual eye.
  • U.S. Pat. No. 6,050,687 (Bille et al) refers to a method wherein the refractive properties of the eye are measured and wherein consideration is taken to the contribution of the individual surfaces of the eye to the total wavefront aberrations.
  • the method described herein particularly aims at analyzing the topography of the posterior corneal surface in order to improve refractive correction techniques.
  • the corneal data can be used together with other ocular parameters to predict the power and the asphericity of an intraocular lens with the purpose of maximizing the optical performances of the future pseudophakic eye.
  • Antonio Guirao and Pablo Artal in IOVS, 1999, Vol. 40(4), S535 that the shape of the cornea changes with age and becomes more spherical.
  • These studies indicate that the cornea in the subjects provides a positive spherical aberration, which increases slightly with the age.
  • the rotationally symmetric aberration of the anterior corneal surface does not seem to be different between younger and older eye according to results found by T Oshika et al in Investigative Ophthalmology and Visual Science, 1999, Vol.
  • Atchison In Ophthal. Physiol. Opt., 1991, Vol. 11, pp. 137-143 (DA Atchison) it is discussed how to reduce spherical aberrations in intraocular lenses by aspherizing the lens surface.
  • the methods outlined by Atchison are based on geometric transferring calculations, which do not consider diffraction effects and any variations in refractive index along the ray path in inhomogeneous elements. These calculations will lead to errors close to the diffraction limit.
  • WO 98/31299 a ray tracing method is outlined according to which the refraction of the cornea is attempted to be considered for the design of an intraocular lens.
  • the present invention generally relates to an ophthalmic lens and to methods of obtaining said ophthalmic lens that is capable of reducing the aberrations of the eye.
  • aberrations in this context is meant wavefront aberrations. This is based on the understanding that a converging wavefront must be perfectly spherical to form a point image, i.e. if a perfect image shall be formed on the retina of the eye, the wavefront having passed the optical surfaces of the eye, such as the cornea and a natural or artificial lens, must be perfectly spherical. An aberrated image will be formed if the wavefront deviates from being spherical.
  • nonspherical surface will refer to rotationally symmetric, asymmetric and/or irregular surfaces, i.e. all surfaces differing from a sphere.
  • the wavefront aberrations can be expressed in mathematical terms in accordance with different approximate models as is explained in textbook references, such as M. R. Freeman, Optics, Tenth Edition, 1990.
  • the present invention is directed to a method of designing an intraocular lens capable of reducing aberrations of the eye after its implantation.
  • the method comprises a first step of characterizing at least one corneal surface as a mathematical model and by employing the mathematical model calculating the resulting aberrations of the corneal surface.
  • An expression of the corneal aberrations is thereby obtained, i.e. the wavefront aberrations of a spherical wavefront having passed such a corneal surface.
  • the corneal surface is characterized as a mathematical model in terms of a conoid of rotation or in terms of polynomials or a combination thereof.
  • the corneal surface is characterized in terms of a linear combination of polynomials.
  • the second step of the method is to select the power of the intraocular lens, which is done according to conventional methods for the specific need of optical correction of the eye, for example the method described in U.S. Pat. No. 5,968,095 From the information of steps one and two an intraocular lens is modeled, such that a wavefront from an optical system comprising said lens and corneal model obtains reduced aberrations.
  • the optical system considered when modeling the lens typically includes the cornea and said lens, but in the specific case it can also include other optical elements including the lenses of spectacles, or an artificial correction lens, such as a contact lens, a corneal inlay implant or an implantable correction lens depending on the individual situation.
  • Modeling the lens involves selection of one or several lens parameters in a system which contributes to determine the lens shape of a given, pre-selected refractive power. This typically involves the selection of the anterior radius and surface shape, posterior radius and surface shape, the lens thickness and the refractive index of the lens.
  • the lens modeling can be performed with data based on a conventional spherical lens, such as the CeeOn® lenses from Pharmacia Corp., as exemplified with the CeeOn® Edge (Model 911). In such a case, it is preferred to deviate as little as possible from an already clinically approved model.
  • the spherical anterior surface of the conventional starting lens is modeled by selecting a suitable aspheric component.
  • the lens has at least one surface described as a nonsphere or other conoid of rotation. Designing nonspherical surfaces of lenses is a well-known technique and can be performed according to different principles and the description of such surfaces is explained in more detail in our parallel Swedish Patent Application 0000611-4 to which is given reference.
  • the inventive method can be further developed by comparing wavefront aberrations of an optical system comprising the lens and the model of the average cornea with the wavefront aberrations of the average cornea and evaluating if a sufficient reduction in wavefront aberrations is obtained.
  • Suitable variable parameters are found among the above-mentioned physical parameters of the lens, which can be altered so as to find a lens model, which deviates sufficiently from being a spherical lens to compensate for the corneal aberrations.
  • the characterization of at least one corneal surface as a mathematical model and thereby establishing a corneal model expressing the corneal wavefront aberrations is preferably performed by direct corneal surface measurements according to well-known topographical measurement methods which serve to express the surface irregularities of the cornea in a quantifiable model that can be used with the inventive method.
  • Corneal measurements for this purpose can be performed by the ORBSCAN® videokeratograph, as available from Orbtech, or by corneal topography methods, such as EyeSys® from Premier Laser Systems.
  • At least the front corneal surface is measured and more preferably both front and rear corneal surfaces are measured and characterized and expressed together in resulting wavefront aberration terms, such as a linear combination of polynomials which represent the total corneal wavefront aberrations.
  • characterization of corneas is conducted on a selected population with the purpose of expressing an average of corneal wavefront aberrations and designing a lens from such averaged aberrations.
  • Average corneal wavefront aberration terms of the population can then be calculated, for example as an average linear combination of polynomials and used in the lens design method.
  • This aspect includes selecting different relevant populations, for example in age groups, to generate suitable average corneal surfaces.
  • lenses can thereby be provided which are adapted to an average cornea of a population relevant for an individual elected to undergo cataract surgery or refractive correction surgery including implantation of an IOL or corneal inlays.
  • the patient will thereby obtain a lens that gives the eye substantially less aberrations when compared to a conventional spherical lens.
  • the mentioned corneal measurements also include the measurement of the corneal refractive power.
  • the power of the cornea and the axial eye length are typically considered for the selection of the lens power in the inventive design method.
  • the wavefront aberrations herein are expressed as a linear combination of polynomials and the optical system comprising the corneal model and modeled intraocular lens provides for a wavefront having obtained a substantial reduction in aberrations, as expressed by one or more such polynomial terms.
  • the polynomials are Seidel or Zernike polynomials. According to the present invention Zernike polynomials preferably are employed.
  • the technique of employing Zernike terms to describe wavefront aberrations originating from optical surfaces deviating from being perfectly spherical is a state of the art technique and can be employed for example with a Hartmann-Shack sensor as outlined in J. Opt. Soc. Am., 1994, Vol. 11(7), pp. 1949-57. It is also well established among optical practitioners that the different Zernike terms signify different aberration phenomena including defocus, astigmatism, coma and spherical aberration up to higher aberrations.
  • the corneal surface measurement results in that a corneal surface is expressed as a linear combination of the first 15 Zernike polynomials.
  • the Zernike description can be transformed to a resulting wavefront (as described in Equation (1)), wherein Z i is the i-th Zernike term and a i is the weighting coefficient for this term.
  • ⁇ and ⁇ represent the normalized radius and the azimuth angle, respectively.
  • Defocus 5 ⁇ square root over (6) ⁇ ( ⁇ 2 sin2 ⁇ ) Astigmatism 1 st order (45°) 6 ⁇ square root over (6) ⁇ ( ⁇ 2 cos2 ⁇ ) Astigmatism 1 st order (0°) 7 ⁇ square root over (8) ⁇ (3 ⁇ 3 ⁇ 2 ⁇ )sin ⁇ Coma y 8 ⁇ square root over (8) ⁇ (3 ⁇ 3 ⁇ 2 ⁇ )cos ⁇ Coma x 9 ⁇ square root over (8) ⁇ ( ⁇ 3 sin3 ⁇ ) Trifoil 30° 10 ⁇ square root over (8) ⁇ ( ⁇ 3 cos3 ⁇ ) Trifoil 0° 11 ⁇ square root over (5) ⁇ (6 ⁇ 4 ⁇ 6 ⁇ 2 + 1)
  • the inventive method further includes to calculate the wavefront aberrations resulting from an optical system comprising said modeled intraocular lens and cornea and expressing it in a linear combination of polynomials and to determine if the intraocular lens has provided sufficient reduction in wavefront aberrations. If the reduction in wavefront aberrations is found to be insufficient, the lens will be re-modeled until one or several of the polynomial terms are sufficiently reduced. Remodeling the lens means that at least one lens design parameter is changed. These include the anterior surface shape and central radius, the posterior surface shape and central radius, the thickness of the lens and its refractive index. Typically, such remodeling includes changing the shape of a lens surface so it deviates from being a spherical.
  • OSLO version 5 see Program Reference, Chapter 4, Sinclair Optics 1996.
  • the format of the Zernike polynomials associated with this application are listed in Table 1.
  • the inventive method comprises expressing at least one corneal surface as a linear combination of Zemike polynomials and thereby determining the resulting corneal wavefront Zernike coefficients, i.e. the coefficient of each of the individual Zernike polynomials that is selected for consideration.
  • the lens is then modeled so that an optical system comprising of said model lens and cornea provides a wavefront having a sufficient reduction of selected Zernike coefficients.
  • the method can optionally be refined with the further steps of calculating the Zernike coefficients of the Zernike polynomials representing a wavefront resulting from an optical system comprising the modeled intraocular lens and cornea and determining if the lens has provided a sufficient reduction of the wavefront Zernike coefficients of the optical system of cornea and lens; and optionally re-modeling said lens until a sufficient reduction in said coefficients is obtained.
  • the method considers Zemike polynomials up to the 4th order and aims to sufficiently reduce Zernike coefficients referring to spherical aberration and/or astigmatism terms.
  • the design method can also include reducing higher order aberrations and thereby aiming to reduce Zernike coefficients of higher order aberration terms than the 4 th order.
  • the corneal surfaces of each individual are expressed in Zemike polynomials describing the surface topography and therefrom the Zernike coefficients of the wavefront aberration are determined. From these results average Zernike wavefront aberration coefficients are calculated and employed in the design method, aiming at a sufficient reduction of selected such coefficients.
  • average values of the Zernike polynomials describing the surface topography are instead calculated and employed in the design method. It is to be understood that the resulting lenses arriving from a design method based on average values from a large population have the purpose of substantially improving visual quality for all users.
  • a lens having a total elimination of a wavefront aberration term based on an average value may consequently be less desirable and leave certain individuals with an inferior vision than with a conventional lens. For this reason, it can be suitable to reduce the selected Zernike coefficients only to certain degree of the average value.
  • corneal characteristics of a selected population and the resulting linear combination of polynomials, e.g. Zernike polynomials, expressing each individual corneal aberration can be compared in terms of coefficient values.
  • a suitable value of the coefficients is selected and employed in the inventive design method for a suitable lens.
  • a coefficient value can typically be the lowest value within the selected population and the lens designed from this value would thereby provide improved visual quality for all individuals in the group compared to a conventional lens.
  • One embodiment of the method comprises selecting a representative group of patients and collecting corneal topographic data for each subject in the group.
  • the method comprises further transferring said data to terms representing the corneal surface shape of each subject for a preset aperture size representing the pupil diameter. Thereafter a mean value of at least one corneal surface shape term of said group is calculated, so as to obtain at least one mean corneal surface shape term. Alternatively or complementary a mean value of at least one to the cornea corresponding corneal wavefront aberration term can be calculated.
  • the corneal wavefront aberration terms are obtained by transforming corresponding corneal surface shape terms using a raytrace procedure. From said at least one mean corneal surface shape term or from said at least one mean corneal wavefront aberration term an ophthalmic lens capable of reducing said at least one mean wavefront aberration term of the optical system comprising cornea and lens is designed.
  • the method further comprises designing an average corneal model for the group of people from the calculated at least one mean corneal surface shape term or from the at least one mean corneal wavefront aberration term. It also comprises checking that the designed ophthalmic lens compensates correctly for the at least one mean aberration term. This is done by measuring these specific aberration terms of a wavefront having traveled through the model average cornea and the lens. The lens is redesigned if said at least one aberration term has not been sufficiently reduced in the measured wavefront.
  • one or more surface descriptive (asphericity describing) constants are calculated for the lens to be designed from the mean corneal surface shape term or from the mean corneal wavefront aberration terms for a predetermined radius.
  • the spherical radius is determined by the refractive power of the lens.
  • the corneal surfaces are preferably characterized as mathematical models and the resulting aberrations of the corneal surfaces are calculated by employing the mathematical models and raytracing techniques. An expression of the corneal wavefront aberrations is thereby obtained, i.e. the wavefront aberrations of a wavefront having passed such a corneal surface. Dependent on the selected mathematical model different routes to calculate the corneal wavefront aberrations can be taken.
  • the corneal surfaces are characterized as mathematical models in terms of a conoid of rotation or in terms of polynomials or a combination thereof. More preferably, the corneal surfaces are characterized in terms of linear combinations of polynomials.
  • the at least one nonspheric surface of the lens is designed such that the lens, in the context of the eye, provides to a passing wavefront at least one wavefront aberration term having substantially the same value but with opposite sign to a mean value of the same aberration term obtained from corneal measurements of a selected group of people, to which said patient is categorized.
  • a wavefront arriving from the cornea of the patient's eye obtains a reduction in said at least one aberration term provided by the cornea after passing said lens.
  • the used expression ‘in the context of the eye’ can mean both in the real eye and in a model of an eye.
  • the wavefront obtains reduced aberration terms expressed in rotationally symmetric Zernike terms up to the fourth order.
  • the surface of the ophthalmic lens is designed to reduce a positive spherical aberration term of a passing wavefront.
  • the ophthalmic lens will provide the optical system comprising the cornea and the ophthalmic lens with a negative wavefront spherical aberration term.
  • positive spherical aberration is defined such that a spherical surface with positive power produces positive spherical aberration.
  • the lens is adapted to compensate for spherical aberration and more preferably it is adapted to compensate for at least one term of a Zernike polynomial representing the aberration of a wavefront, preferably at least the 11 th Zemike term, see Table 1.
  • the selected groups of people could for example be a group of people belonging to a specific age interval, a group of people who will undergo a cataract surgical operation or a group of people who have undergone corneal surgery including but not limited to LASIK (laser in situ keratomileusis), RK (radial keratotomy) or PRK (photorefractive keratotomy).
  • the group could also be a group of people who have a specific ocular disease or people who have a specific ocular optical defect.
  • the lens is also suitably provided with an optical power. This is done according to conventional methods for the specific need of optical correction of the eye. Preferably the refractive power of the lens is less than or equal to 30 diopters.
  • An optical system considered when modeling the lens to compensate for aberrations typically includes the average cornea and said lens, but in the specific case it can also include other optical elements including the lenses of spectacles, or an artificial correction lens, such as a contact lens, a corneal inlay or an implantable correction lens depending on the individual situation.
  • the ophthalmic lens is designed for people who will undergo a cataract surgery.
  • the conic constant of the prolate surface ranges between about ⁇ 0.05 for an aperture size (pupillary diameter) of 4 mm to about ⁇ 0.18 for an aperture size of 7 mm. Accordingly an ophthalmic lens suitable to improve visual quality by reducing at least spherical aberration for a cataract patient based on an average corneal value will have a prolate surface following the formula above. Since cornea generally produces a positive spherical aberration to a wavefront in the eye, an ophthalmic lens for implantation into the eye will have negative spherical aberration terms while following the mentioned prolate curve.
  • an intraocular lens that can correct for 100% of a mean spherical aberration has a conical constant (cc) with a value of less than 0 (representing a modified conoid surface), with an exact value dependent on the design pupillary diameter and the selected refractive power.
  • cc conical constant
  • a 6 mm diameter aperture will provide a 22 diopter lens with conical constant value of about ⁇ 1.03.
  • the ophthalmic lens is designed to balance the spherical aberration of a cornea that has a Zernike polynomial coefficient representing spherical aberration of the wavefront aberration with a value in the interval from 0.000156 mm to 0.001948 mm for a 3 mm aperture radius, 0.000036 mm to 0.000448 mm for a 2 mm aperture radius, 0.0001039 mm to 0.0009359 mm for a 2.5 mm aperture radius and 0.000194 mm to 0.00365 mm for a 3.5 mm aperture radius using polynomials expressed in OSLO format.
  • These values were calculated for a model cornea having a single surface with a refractive index of the cornea of 1.3375.
  • optically equivalent model formats of the cornea without departing from the scope of the invention.
  • multiple surface corneas or corneas with different refractive indices could be used.
  • the lower values in the intervals are here equal to the measured average value for that specific aperture radius minus one standard deviation.
  • the higher values are equal to the measured average value for each specific aperture radius plus three standard deviations.
  • the method further comprises the steps of measuring the at least one wavefront aberration term of one specific patient's cornea and determining if the selected group corresponding to this patient is representative for this specific patient. If this is the case the selected lens is implanted and if this is not the case a lens from another group is implanted or an individual lens for this patient is designed using this patients corneal description as a design cornea. These method steps are preferred since then patients with extreme aberration values of their cornea can be given special treatments.
  • the present invention is directed to the selection of an intraocular lens of refractive power, suitable for the desired optical correction that the patient needs, from a plurality of lenses having the same power but different aberrations.
  • the selection method is similarly conducted to what has been described with the design method and involves the characterizing of at least one corneal surface with a mathematical model by means of which the aberrations of the corneal surface is calculated.
  • the optical system of the selected lens and the corneal model is then evaluated so as to consider if sufficient reduction in aberrations is accomplished by calculating the aberrations of a wavefront arriving from such a system. If an insufficient correction is found a new lens is selected, having the same power, but different aberrations.
  • the mathematical models employed herein are similar to those described above and the same characterization methods of the corneal surfaces can be employed.
  • the aberrations determined in the selection are expressed as linear combinations of Zemike polynomials and the Zernike coefficients of the resulting optical system comprising the model cornea and the selected lens are calculated. From the coefficient values of the system, it can be determined if the intraocular lens has sufficiently balanced the corneal aberration terms, as described by the Zernike coefficients of the optical system. If no sufficient reduction of the desired individual coefficients are found these steps can be iteratively repeated by selecting a new lens of the same power but with different aberrations, until a lens capable of sufficiently reducing the aberrations of the optical system is found. Preferably at least 15 Zernike polynomials up to the 4 th order are determined.
  • the intraocular lens shall be selected so a selection of these terms become sufficiently small for the optical system comprising lens and cornea.
  • the 11 th Zernike coefficient, a 11 can be substantially eliminated or brought sufficiently close to zero. This is a prerequisite to obtain an intraocular lens that sufficiently reduces the spherical aberration of the eye.
  • the inventive method can be employed to correct for other types of aberrations than spherical aberration by considering other Zernike coefficients in an identical manner, for example those signifying astigmatism, coma and higher order aberrations. Also higher order aberrations can be corrected dependent on the number of Zernike polynomials elected to be a part of the modeling, in which case a lens can be selected capable of correcting for higher order aberrations than the 4 th order.
  • the selection method involves selecting lenses from a kit of lenses having lenses with a range of power and a plurality of lenses within each power having different aberrations.
  • the lenses within each power have anterior surfaces with different aspherical components. If a first lens does not exhibit sufficient reduction in aberration, as expressed in suitable Zernike coefficients, then a new lens of the same power, but with a different surface (aspheric component) is selected.
  • the selection method can if necessary be iteratively repeated until the best lens is found or the studied aberration terms are reduced below a significant borderline value.
  • the Zernike terms obtained from the corneal examination will be directly obtained by the ophthalmic surgeon and by means of an algorithm they will be compared to known Zernike terms of the lenses in the kit. From this comparison the most suitable lens in the kit can be found and implanted.
  • the method can be conducted before cataract surgery and data from the corneal estimation is sent to a lens manufacturer for production of an individually tailored lens.
  • the present invention further pertains to an intraocular lens having at least one nonspherical surface capable of transferring a wavefront having passed through the cornea of the eye into a substantially spherical wavefront with its center at the retina of the eye.
  • the wavefront is substantially spherical with respect to aberration terms expressed in rotationally symmetric Zernike terms up to the fourth order.
  • the invention relates to an intraocular lens, which has at least one surface, when expressed as a linear combination of Zernike polynomial terms using the normalized format, that has a negative 11 th term of the fourth order with a Zernike coefficient a 11 that that can balance a positive such term of the cornea to obtain sufficient reduction of the spherical aberration of the eye after implantation.
  • the Zernike coefficient a 11 of the lens is determined so as to compensate for an average value resulting from a sufficient number of estimations of the Zernike coefficient al in several corneas.
  • the Zernike coefficient a 11 is determined to compensate for the individual corneal coefficient of one patient.
  • the lens can accordingly be tailored for an individual with high precision.
  • the invention further relates to another method of providing a patient with an intraocular lens, which at least partly compensates for the aberrations of the eye.
  • This method comprises removing the natural lens from the eye. Surgically removing the impaired lens can be performed by using a conventional phacoemulsification method.
  • the method further comprises measuring the aberrations of the aphakic eye, not comprising a lens, by using a wavefront sensor. Suitable methods for wavefront measurements are found in J.Opt.Soc.Am., 1994, Vol. 11(7), pp. 1949-57 by Liang et. al.
  • the method comprises selecting from a kit of lenses a lens that at least partly compensates for the measured aberrations and implanting said lens into the eye.
  • the kit of lenses comprises lenses of different power and different aberrations and finding the most suitable lens can be performed in a manner as earlier discussed.
  • an individually designed lens for the patient can be designed based on the wavefront analysis of the aphakic eye for subsequent implantation. This method is advantageous, since no topographical measurements of the cornea are and the whole cornea, including the front and back surfaces, is automatically considered.
  • the lenses according to the present invention can be manufactured with conventional methods. In one embodiment they are made from soft, resilient material, such as silicones or hydrogels. Examples of such materials suitable for foldable intraocular lenses are found in U.S. Pat. No. 5,444,106 or in U.S. Pat. No. 5,236,970. Manufacturing of nonspherical silicone lenses or other foldable lenses can be performed according to U.S. Pat. No. 6,007,747. Alternatively, the lenses according to the present invention can be made of a more rigid material, such as poly(methyl)methacrylate. The skilled person can readily identify alternative materials and manufacturing methods, which will be suitable to employ to produce the inventive aberration reducing lenses.
  • soft, resilient material such as silicones or hydrogels. Examples of such materials suitable for foldable intraocular lenses are found in U.S. Pat. No. 5,444,106 or in U.S. Pat. No. 5,236,970. Manufacturing of nonspherical silicone lenses or other foldable lenses can be performed according to U.S. Pat.
  • FIG. 1 shows a comparison of the a 11 (“Z11”) Zernike coefficient values for 10 subjects if implanted with CeeOn® 911 lenses and the inventive averaged (“Z11”) lens.
  • FIG. 2 shows modeled visual acuities of the test subjects with CeeOn® 911 lenses and the inventive averaged (“Z11”) lenses.
  • FIG. 3 and FIG. 4 show modulation transfer function comparisons between CeeOn® 911 lenses and the inventive averaged (“Z11”) lenses
  • FIG. 5 shows visual acuity plotted as a function of the astigmatism of the lenses according to the model lenses according to the invention.
  • FIG. 6 shows the best corrected visual acuity with the inventive lenses.
  • FIG. 7 and 8 show modulation transfer functions of an individual with an individually designed lens.
  • FIG. 9 shows the best corrected visual acuity with individually designed lenses according to the invention.
  • FIG. 10 shows the age distribution of 71 patients used in a study described below in the example part.
  • FIG. 11 shows a height map given by an Orbscan® true height data file.
  • FIG. 12 shows average corneal wavefront aberration coefficients.
  • FIG. 13 shows a scatter plot of the spherical aberration of 71 subjects for a 6 mm diameter aperture.
  • FIG. 14 shows a scatter plot of the spherical aberration of 71 subjects for a 4 mm diameter aperture.
  • FIG. 15 shows a scatter plot of the spherical aberration of 71 subjects for a 5 mm diameter aperture.
  • FIG. 16 shows a scatter plot of the spherical aberration of 71 subjects for a 7 mm diameter aperture.
  • the sag data of the corneas was determined using the real height data measured with a Humphrey Atlas corneal topographer.
  • the corneal topographer measures the height (z i ) at a discrete number of points.
  • the corneal surface can then be expressed as a linear combination of the first 15 Zemike polynomials (as described in Equation 1, above), where Z i is the ith Zemike polynomial and a i is the weighting coefficient for this polynomial.
  • the Zemike polynomials are a set of complete orthogonal polynomials defined on a unit circle.
  • OSLO numbering order Aberration Coefficients for FCM (OSLO) A0 ⁇ 0.000123 A1 4.5960e ⁇ 07 A2 2.0869e ⁇ 07 A3 ⁇ 5.355e ⁇ 06 A4 0.000551 A5 0.000182 A6 3.7296e ⁇ 05 A7 ⁇ 5.5286e ⁇ 05 A8 0.000116 A9 ⁇ 0.000217 A10 ⁇ 0.000147 A11 ⁇ 3.8151e ⁇ 05 A12 6.1808e ⁇ 05 A13 ⁇ 3.3056e ⁇ 07 A14 4.888e ⁇ 07 A15 ⁇ 1.8642e ⁇ 06 A16 ⁇ 0.000115 A17 ⁇ 0.000127
  • An averaged design embodiment of the inventive lenses has been calculated using the average “old” cornea information provided by Pablo Artal, Murcia, Spain. This data was taken from a population sample of 16 old corneas in which all of the subjects had a visual acuity of 20/30 or better.
  • the corneal surfaces were described using Zernike polynomials for an aperture of 2.0 mm radius (r o ). The polynomial coefficients were then used to determine the radius and asphericity values using Equations 2 and 3.
  • R r o 2 2 ⁇ ( 2 ⁇ 3 ⁇ a 4 - 6 ⁇ ⁇ 5 ⁇ a 11 ) ( 2 )
  • K 2 8 ⁇ ⁇ R 3 r o 4 ⁇ 6 ⁇ 5 ⁇ a 11 ( 3 )
  • the calculated R and K are also only accurate over the central 4 mm.
  • a pupil size of 4.0 mm is therefore selected for design purposes. This pupil size is reasonable for intraocular lens design purposes.
  • the wavefront aberration coefficients in mm for the average cornea are shown in column 1 of Table 5, while the coefficients in mm of the combination of the average cornea and the 911 lens are shown in column 2 of Table 5.
  • the Z11 coefficient (a11) of the average old cornea alone is 0.000220 mm, while the Z11 of this eye implanted with a 911 would be 0.000345 mm.
  • the averaged lens was optimized to minimize spherical aberration, while maintaining a 22D focal power.
  • the lens material remained the same as in the 22D 911 lens (MRI silicone, the refractive index of which is 1.45 in 77 at 37° C.
  • the resulting design for an equiconvex lens is The averaged lens was optimized to minimize spherical aberration, while maintaining a 22D focal power.
  • the lens material remained the same as in the 22D 911 lens (HRI silicone, the refractive
  • the resulting design for an equiconvex lens is provided in Table 6.
  • the total-eye Z11 coefficient of the average cornea combined with this lens is ⁇ 2.42 ⁇ 10 ⁇ 7 mm(versus 0.000345 mm for the cornea plus 911 lens).
  • the corneas of the 10 test subjects were combined in an optical system with both the 911 and the averaged lenses.
  • the resulting total-eye Z11 coefficients are shown in FIG. 1 .
  • the absolute value of the Z11 coefficient was less when the Z11 lens was implanted.
  • the total-eye spherical aberration is overcorrected in these two cases.
  • the sign of the total spherical aberration is noticeably reversed in these two cases, and the amount of spherical aberration is still significant.
  • the spherical aberration of the total eye would be essentially 0 after the implantation of a Z11 lens.
  • the visual acuity of each of the 10 test subjects were calculated according to standard methods described in “Visual acuity modeling using optical raytracing of schematic eyes”, Greivenkamp et al., American journal of ophthalmology, 120(2), 227-240, (1995), for the implantation of both a 22D 911 lens and a 22D averaged “Z11” lens.
  • the square wave responses were calculated using OSLOTM and a software module was written in MatlabTM to calculate the visual acuity following the above method.
  • the resulting visual acuities are shown in FIG. 2 .
  • Out of the 10 cases investigated and shown in FIG. 2 eight subjects had better vision when implanted with the averaged lens according to the present invention. In the cases where the visual acuity decreased their Snellen distance increased by less than 1 ft which would not show up in visual acuity testing.
  • a physical model of the average cornea was designed and manufactured. It is a convex-plano lens of PMMA with an aspheric front surface having a value of 0.000218 for Zernike coefficient al 1. This value is almost equal to the value of the calculated average cornea: 0.000220.
  • MTF Modulation Transfer Function
  • the astigmatism of the cornea and the defocus of the system can be corrected by adjusting the Zernike coefficients of the cornea model and the focal position of the system.
  • the results in FIG. 6 are obtained. They represent a modeled best corrected visual acuity.
  • an individualized lens (“I11 lenses”) was designed for each of four subject corneas employing the same design principles as demonstrated in Example 2.
  • the individual lenses were designed such that the Z11 of the lens balances the Z11 of the individual cornea.
  • the total-eye Z11 coefficients for the I11 lenses are shown in Table 7, together TABLE 7
  • the Z11 coefficients in mm of the model eyes with the 911, Z11 and I11 lenses Subject 911 averaged individual CGR 0.000107 ⁇ 0.000101 ⁇ 0.000004 FCZ 0.000105 ⁇ 0.000100 ⁇ 0.000005 JAE 0.000195 ⁇ 0.000016 ⁇ 0.000012 JBH 0.000238 0.000037 ⁇ 0.000019 with the corresponding coefficients for the 911 and the averaged lenses.
  • the MTF curve at best focussed at 50 c/mm and the through focus MTF at 50 c/mm for subject JAE are plotted below in FIG. 7 and 8 . From FIG. 7 and 8 , it is seen that the MTF at 50 c/mrn of eyes implanted with the Z11 and I11 lenses is higher than the MTF of the same eyes implanted with 911 lenses. It can also be seen that the through focus MTF of all of the lenses is satisfactory. The Z 11 has as much depth of focus as the 911. However, it is also interesting to note that the I11 does not provide a significant improvement in either MTF or through focus MTF, relative to the Z11 lens.
  • FIG. 9 compares these acuities with the visual acuity calculated for the 911 and Z11 lenses.
  • the design of an ophthalmic lens which is adapted to reduce the spherical aberration of an average cornea obtained from a group of people will be described in detail here below.
  • the lens will be called the Z11. lens because it compensates for the normalized 11 th Zernike term describing spherical aberration of the corneas. It was decided to use a population of potential recipients of the Z11 lens, namely cataract patients.
  • Orbscan® is a scanning slit-based, corneal and anterior segment topographer that measures both surfaces of the cornea, as well as the anterior lens surface and the iris. Each surface can be displayed as maps of elevation, inclination, curvature, and power.
  • the corneal elevation height data (the Cartesian locations of points on the surface of the cornea) for the anterior surface was obtained using the Orbscan®, and used as raw data for the determination of the optical properties of the cornea.
  • the height data from an example Orbscan® file is represented in FIG. 11 .
  • Cartesian co-ordinates representing the elevation height data are transformed to polar co-ordinates (x,y,z ⁇ r, ⁇ ,z).
  • this data is then fit to a series of polynomials as described in Equation lb.
  • the coefficients (a's), or weighting factors, for each polynomial are determined by the fitting procedure resulting in a complete description of the surface.
  • the polynomials (Z i ) used are the normalized Zernike polynomials.
  • the fitting procedure is well described in a number of references. Four different articles are refereed to here: “Wavefront fitting with discrete orthogonal polynomials in a unit radius circle”, Daniel Malacara, Optical Engineering, June 1990, Vol. 29 No. 6, “Representation of videolceratoscopic height data with Zernike polynomials”, J. Schwiegerling, J. Greivenkamp and J. Miller, JOSA A, October 1995, Vol. 12 No.
  • the 71 subjects were evaluated using the criteria described above for a 6 mm aperture.
  • the wavefront aberration of each subject was determined after fitting the surface elevation with Zernike polynomials.
  • FIG. 12 shows that average and standard deviation of each Zernike term (normalized format). The error bars represent ⁇ 1 standard deviation.
  • Spherical aberration is the only rotationally symmetric aberration, making it the only aberration that can be corrected with a rotationally symmetric IOL.
  • FIG. 13 shows a scatter plot of the value of the Zernike coefficient (OSLO format) representing spherical aberration for each of the 71 subjects before cataract surgery.
  • the solid line in the middle represents the average spherical aberration, while the dotted lines represent +1 and ⁇ 1 standard deviation.
  • Table 8 lists the average, standard deviation, maximum and minimum values for the radius, aspheric constant, spherical aberration and root mean square error. TABLE 8 the average, standard deviation, maximum and minimum values for the radius, aspheric constant, spherical aberration and root mean square error for a 6 mm aperture.
  • Tables 9, 10 and 11 below show the corresponding results for aperture sizes of 4, 5 and 7 mm respectively.
  • FIG. 14, 15 and 16 are the corresponding scatter plots.
  • TABLE 9 The average, standard deviation, maximum and minimum values for the radius, aspheric constant, spherical aberration and root mean square error using an aperture diameter of 4 mm. Average Value Standard Deviation Maximum Minimum R 7.56292 0.320526 8.688542 7.067694 Ksq 0.988208 0.437429 2.33501 ⁇ 0.051091 SA (A11 0.000139 0.000103 0.00041 ⁇ 0.000141 in mm) RMSE 4.52E ⁇ 05 4E ⁇ 06 0.000054 0.000036
  • the design cornea radii and aspheric constants are listed in Table 12 for different aperture sizes. In every case, the radius of curvature was taken to be the average radius determined from the Zernike fit data. The aspheric constant was varied until the spherical aberration value of the model cornea was equal to the average spherical aberration value for the population. TABLE 12 The design cornea radii and aspheric constants for aperture diameters of 4, 5, 6, and 7 mm.
  • Aperture Conic Constant Z11 size (mm) Radius (mm) (OSLO value, K 2 ⁇ 1) Coefficient (mm) 4 7.563 ⁇ 0.0505 0.000139 5 7.553 ⁇ 0.1034 0.000312 6 7.575 ⁇ 0.14135 0.000604 7 7.55 ⁇ 0.1810 0.001058
  • the 6 mm aperture diameter values are used for the design cornea. This choice enables us to design the Z11 lens so that it has no spherical aberration (when measured in a system with this cornea) over a 5.1 mm lens diameter.
  • the OSLO surface listing for the Z11 design cornea is listed in Table 13.
  • the refractive index of the cornea is the keratometry index of 1.3375.
  • Each Z11 lens was designed to balance the spherical aberration of the design cornea.
  • the starting point for design was the CeeOn Edge ⁇ 911 lens described in U.S. Pat. No. 5,444,106 of the same power, with modified edge and center thickness.
  • the lens was then placed 4.5 mm from the anterior corneal surface. The distance from the anterior corneal surface is not that critical and could be varied within reasonable limits.
  • the surface information for the starting point eye model for the 22D lens design process is listed in Table 14.
  • the anterior surface of the lens was described using the formula shown in Equation 4.
  • the variables cc, ad and ae were modified to minimize the spherical aberration.
  • the variables are determined for an aperture size of 5.1 mm and the surface is extrapolated from these values to the optical aperture size of 6 mm.
  • the resulting 22D Z11 eye model is listed in Table 15.
  • the anterior surface of this 22D lens has been modified in such a way that the spherical aberration of the system (cornea+lens) is now approximately equal to 0.
  • the wavefront aberration coefficients as calculated by OSLO for the CeeOn Edge 911 22D lens eye model and the 22D Z11 lens eye model are listed below in Table 16.
  • the coefficient representing spherical aberration for the starting point eye model is 0.001005 mm for a 6 mm diameter aperture placed at the cornea, while the same coefficient for the eye model with the designed Z11 lens is ⁇ 1.3399e-06 mm.
  • the same process as described above for a 22D lens can similarly be performed for any other lens power.
  • the optical form chosen for the new Z11 design is an equiconvex lens made from a silicone with refractive index of 1.458.
  • the spherical aberration of an average cornea is balanced by the Z11 lens yielding a system without spherical aberration.
  • the front surface of the lens is modified such that the optical path lengths of all on-axis rays within the design aperture are the same producing a point focus. This feature can be achieved with many lens forms.
  • the Z11 lens could therefore be designed on a convex-plano, plano-convex, non-equiconvex lens or any other design yielding a positive lens.
  • the Z11 concept could also be extended in order to encompass a negative lens used to correct the refractive errors of the eye.
  • the front surface or back surface could also be modified to produce the needed change in optical path difference that neutralizes the spherical aberration. There are therefore many possible designs that would achieve the goals of the Z11 lens design.

Abstract

The present invention discloses methods of obtaining ophthalmic lens capable of reducing the aberrations of the eye comprising the steps of characterizing at least one corneal surface as a mathematical model, calculating the resulting aberrations of said corneal surface(s) by employing said mathematical model, selecting the optical power of the intraocular lens. From this information, an ophthalmic lens is modeled so a wavefront arriving from an optical system comprising said lens and corneal model obtains reduced aberrations in the eye. Also disclosed are ophthalmic lenses as obtained by the methods which are capable reducing aberrations of the eye.

Description

    RELATED APPLICATIONS
  • The present application is a continuation application of U.S. Ser. No. 10/606,910, filed Jun. 26, 2003, which is a divisional application of U.S. Ser. No. 09/863,546, filed May 23, 2001, now U.S. Pat. No. 6,609,793, issued Aug. 26, 2003, which was the non-provisional application of Provisional Application No. 60/259,924 filed Jan. 5, 2001, now expired and Provisional Application No. 60/207,734 filed May 26, 2000, now expired.
  • FIELD OF THE INVENTION
  • The present invention relates to methods of designing ophthalmic lenses that provide the eye with reduced aberrations, as well as lenses capable of providing such-visual improvements.
  • BACKGROUND OF THE INVENTION
  • It is presently discussed that the visual quality of eyes having an implanted intraocular lens (IOL) is comparable with normal eyes in a population of the same age. Consequently, a 70 year old cataract patient can only expect to obtain the visual quality of a non-cataracteous person of the same age after surgical implantation of an intraocular lens, although such lenses objectively have been regarded as optically superior to the natural crystalline lens. This result is likely to be explained by the fact that present IOLs are not adapted to compensate for defects of the optical system of the human eye, namely optical aberrations. Age-related defects of the eye have recently been investigated and it is found that contrast sensitivity significantly declines in subjects older than 50 years. These results seem to comply with the above-mentioned discussion, since the contrast sensitivity measurements indicate that individuals having undergone cataract surgery with lens implantation lens will not obtain a better contrast sensitivity than non-cataracteous persons of an average age of about 60 to 70 years.
  • Even if intraocular lenses aimed at substituting the defective cataract lens and other ophthalmic lenses, such as conventional contact lenses, have been developed with excellent optical quality as isolated elements, it is obvious that they fail to correct for a number of aberration phenomena of the eye including age-related aberration defects.
  • U.S. Pat. No. 5,777,719 (Williams et al.) discloses a method and an apparatus for accurately measuring higher order aberrations of the eye as an optical system with wavefront analysis. By using a Hartmann-Shack wavefront sensor, it is possible to measure higher order aberrations of the eye and use such data to find compensation for these aberrations and thereby obtain sufficient information for the design of an optical lens, which can provide a highly improved optical performance. The Hartmann-Shack sensor provides means for analyzing light reflected from a point on the retina of the eye of a subject. The wavefront in the plane of the pupil is recreated in the plane of the lenslet array of the Hartmann-Shack sensor. Each lenslet in the array is used to form an aerial image of the retinal point source on a CCD camera located at the focal plane of the array. The wave aberration of the eye, in the form resulting from a point source produced on the retina by a laser beam, displaces each spot by an amount proportional to the local slope of the wavefront at each of the lenslets. The output from the CCD camera is sent to a computer, which then performs calculations to fit slope data to the first derivatives of 66 Zernike polynomials. From these calculations, coefficients for weighting the Zernike polynomials are obtained. The sum of the weighted Zernike polynomials represents a reconstructed wavefront distorted by the aberrations of the eye as an optical system. The individual Zemike polynomial terms will then represent different modes of aberration.
  • U.S. Pat. No. 5,050,981 (Roffman) discloses another method for designing a lens by calculating modulation transfer functions from tracing a large number of rays through the lens-eye system and evaluating the distribution density of the rays in the image position. This is repeatedly performed by varying at least one lens surface until a lens is found which results in a sharp focus and a maximum modulation transfer function.
  • U.S. Pat. No. 6,224,211 (Gordon) describes a method of improving the visual acuity of the human eye by successively fitting aspheric lenses to the cornea and thereby finding a lens that can reduce spherical aberration of the whole individual eye.
  • The methods referred to above for designing are suitable for the design of contact lenses or other correction lenses for the phakic eye which can be perfected to compensate for the aberration of the whole eye system. However, to provide improved intraocular lenses aimed to replace the natural crystalline lens, it would be necessary to consider the aberrations of the individual parts of the eye.
  • U.S. Pat. No. 6,050,687 (Bille et al) refers to a method wherein the refractive properties of the eye are measured and wherein consideration is taken to the contribution of the individual surfaces of the eye to the total wavefront aberrations. The method described herein particularly aims at analyzing the topography of the posterior corneal surface in order to improve refractive correction techniques.
  • There has recently been a focus on studying the aberrations of the eye, including a number of studies of the development of these aberrations as a function of age. In two particular studies, the development of the components of the eye were examined separately, leading to the conclusion that the optical aberrations of the individual components of younger eyes cancel each other out, see Optical Letters, 1998, Vol. 23(21), pp. 1713-1715 and IOVS, 2000, Vol.41(4), 545. The article of S. Patel et al in Refractive & Corneal Surgery, 1993, Vol. 9, pages 173-181 discloses the asphericity of posterior corneal surfaces. It is suggested that the corneal data can be used together with other ocular parameters to predict the power and the asphericity of an intraocular lens with the purpose of maximizing the optical performances of the future pseudophakic eye. Furthermore, it was also recently observed by Antonio Guirao and Pablo Artal in IOVS, 1999, Vol. 40(4), S535 that the shape of the cornea changes with age and becomes more spherical. These studies indicate that the cornea in the subjects provides a positive spherical aberration, which increases slightly with the age. On the other hand, the rotationally symmetric aberration of the anterior corneal surface does not seem to be different between younger and older eye according to results found by T Oshika et al in Investigative Ophthalmology and Visual Science, 1999, Vol. 40, pp. 1351-1355. In Vision Research, 1998, 38(2), pp. 209-229, A Glasser et al. investigated the spherical aberration of natural crystalline lenses from eyes obtained from an eye bank after the cornea has been removed. According to the laser scanner optical method used herein it was found that the spherical aberration from an older lens (66 years) shows positive spherical aberration, whereas a 10-year-old lens shows negative spherical aberration. In addition, Vision Research, 2001, 41, pp. 235-243 (G Smith et al) discloses that the natural crystalline lens appears to have negative spherical aberration when in the relaxed state. Smith et al suggest that because older eyes have a larger aberration, it is likely that the spherical aberration of the crystalline lens becomes less negative with age.
  • In Ophthal. Physiol. Opt., 1991, Vol. 11, pp. 137-143 (DA Atchison) it is discussed how to reduce spherical aberrations in intraocular lenses by aspherizing the lens surface. The methods outlined by Atchison are based on geometric transferring calculations, which do not consider diffraction effects and any variations in refractive index along the ray path in inhomogeneous elements. These calculations will lead to errors close to the diffraction limit. Also in WO 98/31299 (Technomed) a ray tracing method is outlined according to which the refraction of the cornea is attempted to be considered for the design of an intraocular lens. In view of the foregoing, it is apparent that there is a need for ophthalmic lenses that are better adapted or compensated to the aberrations of the individual surfaces of the eye and are capable of better correcting aberrations other than defocus and astigmatism, as provided by conventional ophthalmic lenses.
  • DESCRIPTION OF THE INVENTION
  • It is an object of the invention to provide for methods that result in obtaining an ophthalmic lens, which provides the eye with reduced aberrations.
  • It is another object of the invention to provide methods of obtaining an intraocular lens capable of reducing the aberration of the eye after its implantation into the eye.
  • It is a further object to provide for methods of obtaining an intraocular lens capable of compensating the aberrations resulting from optical irregularities in the corneal surfaces.
  • It is a still further object of the present invention to provide an intraocular lens which is capable of restoring a wavefront deviating from sphericity into a substantially more spherical wavefront.
  • It is a also an object of the present invention to provide an intraocular lens which is capable of correcting for mean optical irregularities and imperfections found in a particular group of people and thereby provide a lens with improved optical performance for an individual belonging to the same group.
  • The present invention generally relates to an ophthalmic lens and to methods of obtaining said ophthalmic lens that is capable of reducing the aberrations of the eye. By aberrations in this context is meant wavefront aberrations. This is based on the understanding that a converging wavefront must be perfectly spherical to form a point image, i.e. if a perfect image shall be formed on the retina of the eye, the wavefront having passed the optical surfaces of the eye, such as the cornea and a natural or artificial lens, must be perfectly spherical. An aberrated image will be formed if the wavefront deviates from being spherical. In this context the term nonspherical surface will refer to rotationally symmetric, asymmetric and/or irregular surfaces, i.e. all surfaces differing from a sphere. The wavefront aberrations can be expressed in mathematical terms in accordance with different approximate models as is explained in textbook references, such as M. R. Freeman, Optics, Tenth Edition, 1990.
  • In a first embodiment, the present invention is directed to a method of designing an intraocular lens capable of reducing aberrations of the eye after its implantation. The method comprises a first step of characterizing at least one corneal surface as a mathematical model and by employing the mathematical model calculating the resulting aberrations of the corneal surface. An expression of the corneal aberrations is thereby obtained, i.e. the wavefront aberrations of a spherical wavefront having passed such a corneal surface. Dependent on the selected mathematical model different routes to calculate the corneal aberrations can be taken. Preferably, the corneal surface is characterized as a mathematical model in terms of a conoid of rotation or in terms of polynomials or a combination thereof. More preferably, the corneal surface is characterized in terms of a linear combination of polynomials. The second step of the method is to select the power of the intraocular lens, which is done according to conventional methods for the specific need of optical correction of the eye, for example the method described in U.S. Pat. No. 5,968,095 From the information of steps one and two an intraocular lens is modeled, such that a wavefront from an optical system comprising said lens and corneal model obtains reduced aberrations. The optical system considered when modeling the lens typically includes the cornea and said lens, but in the specific case it can also include other optical elements including the lenses of spectacles, or an artificial correction lens, such as a contact lens, a corneal inlay implant or an implantable correction lens depending on the individual situation.
  • Modeling the lens involves selection of one or several lens parameters in a system which contributes to determine the lens shape of a given, pre-selected refractive power. This typically involves the selection of the anterior radius and surface shape, posterior radius and surface shape, the lens thickness and the refractive index of the lens. In practical terms, the lens modeling can be performed with data based on a conventional spherical lens, such as the CeeOn® lenses from Pharmacia Corp., as exemplified with the CeeOn® Edge (Model 911). In such a case, it is preferred to deviate as little as possible from an already clinically approved model. For this reason, it may be preferred to maintain pre-determined values of the central radii of the lens, its thickness and refractive index, while selecting a different shape of the anterior and/or posterior surface, thus providing one or both of these surfaces to have an nonspherical shape. According to an alternative of the inventive method, the spherical anterior surface of the conventional starting lens is modeled by selecting a suitable aspheric component. Preferably the lens has at least one surface described as a nonsphere or other conoid of rotation. Designing nonspherical surfaces of lenses is a well-known technique and can be performed according to different principles and the description of such surfaces is explained in more detail in our parallel Swedish Patent Application 0000611-4 to which is given reference.
  • The inventive method can be further developed by comparing wavefront aberrations of an optical system comprising the lens and the model of the average cornea with the wavefront aberrations of the average cornea and evaluating if a sufficient reduction in wavefront aberrations is obtained. Suitable variable parameters are found among the above-mentioned physical parameters of the lens, which can be altered so as to find a lens model, which deviates sufficiently from being a spherical lens to compensate for the corneal aberrations.
  • The characterization of at least one corneal surface as a mathematical model and thereby establishing a corneal model expressing the corneal wavefront aberrations is preferably performed by direct corneal surface measurements according to well-known topographical measurement methods which serve to express the surface irregularities of the cornea in a quantifiable model that can be used with the inventive method. Corneal measurements for this purpose can be performed by the ORBSCAN® videokeratograph, as available from Orbtech, or by corneal topography methods, such as EyeSys® from Premier Laser Systems. Preferably, at least the front corneal surface is measured and more preferably both front and rear corneal surfaces are measured and characterized and expressed together in resulting wavefront aberration terms, such as a linear combination of polynomials which represent the total corneal wavefront aberrations. According to one important aspect of the present invention, characterization of corneas is conducted on a selected population with the purpose of expressing an average of corneal wavefront aberrations and designing a lens from such averaged aberrations. Average corneal wavefront aberration terms of the population can then be calculated, for example as an average linear combination of polynomials and used in the lens design method. This aspect includes selecting different relevant populations, for example in age groups, to generate suitable average corneal surfaces. Advantageously, lenses can thereby be provided which are adapted to an average cornea of a population relevant for an individual elected to undergo cataract surgery or refractive correction surgery including implantation of an IOL or corneal inlays. The patient will thereby obtain a lens that gives the eye substantially less aberrations when compared to a conventional spherical lens.
  • Preferably, the mentioned corneal measurements also include the measurement of the corneal refractive power. The power of the cornea and the axial eye length are typically considered for the selection of the lens power in the inventive design method.
  • Also preferably, the wavefront aberrations herein are expressed as a linear combination of polynomials and the optical system comprising the corneal model and modeled intraocular lens provides for a wavefront having obtained a substantial reduction in aberrations, as expressed by one or more such polynomial terms. In the art of optics, several types of polynomials are available to skilled persons for describing aberrations. Suitably, the polynomials are Seidel or Zernike polynomials. According to the present invention Zernike polynomials preferably are employed.
  • The technique of employing Zernike terms to describe wavefront aberrations originating from optical surfaces deviating from being perfectly spherical is a state of the art technique and can be employed for example with a Hartmann-Shack sensor as outlined in J. Opt. Soc. Am., 1994, Vol. 11(7), pp. 1949-57. It is also well established among optical practitioners that the different Zernike terms signify different aberration phenomena including defocus, astigmatism, coma and spherical aberration up to higher aberrations. In an embodiment of the present method, the corneal surface measurement results in that a corneal surface is expressed as a linear combination of the first 15 Zernike polynomials. By means of a raytracing method, the Zernike description can be transformed to a resulting wavefront (as described in Equation (1)), wherein Zi is the i-th Zernike term and ai is the weighting coefficient for this term. Zernike polynomials are a set of complete orthogonal polynomials defined on a unit circle. Below, Table 1 shows the first 15 Zernike terms and the aberrations each term signifies. z ( ρ , θ ) = i = 1 15 a i Z i ( 1 )
  • In equation (1), ρ and θ represent the normalized radius and the azimuth angle, respectively.
    TABLE 1
    i Zi (ρ, θ)
    1 1 Piston
    2 2ρcos θ Tilt x
    3 2ρsinθ Tilt y
    4 {square root over (3)}(2ρ2 − 1) Defocus
    5 {square root over (6)}(ρ2 sin2θ) Astigmatism 1st order (45°)
    6 {square root over (6)}(ρ2 cos2θ) Astigmatism 1st order (0°)
    7 {square root over (8)}(3ρ3 − 2ρ)sinθ Coma y
    8 {square root over (8)}(3ρ3 − 2ρ)cosθ Coma x
    9 {square root over (8)}(ρ3 sin3θ) Trifoil 30°
    10 {square root over (8)}(ρ3 cos3θ) Trifoil
    11 {square root over (5)}(6ρ4 − 6ρ2 + 1) Spherical aberration
    12 {square root over (10)}(4ρ4 − 3ρ2)cos2θ Astigmatism 2nd order (0°)
    13 {square root over (10)}(4ρ4 − 3ρ2)sin2θ Astigmatism 2nd order (45°)
    14 {square root over (10)}(ρ4 cos4θ) Tetrafoil
    15 {square root over (10)}(ρ4 sin4θ) Tetrafoil 22.5°
  • Conventional optical correction with intraocular lenses will only comply with the fourth term of an optical system comprising the eye with an implanted lens. Glasses, contact lenses and some special intra ocular lenses provided with correction for astigmatism can further comply with terms five and six and substantially reducing Zernike polynomials referring to astigmatism.
  • The inventive method further includes to calculate the wavefront aberrations resulting from an optical system comprising said modeled intraocular lens and cornea and expressing it in a linear combination of polynomials and to determine if the intraocular lens has provided sufficient reduction in wavefront aberrations. If the reduction in wavefront aberrations is found to be insufficient, the lens will be re-modeled until one or several of the polynomial terms are sufficiently reduced. Remodeling the lens means that at least one lens design parameter is changed. These include the anterior surface shape and central radius, the posterior surface shape and central radius, the thickness of the lens and its refractive index. Typically, such remodeling includes changing the shape of a lens surface so it deviates from being a spherical. There are several tools available in lens design that are useful to employ with the design method, such as OSLO version 5 see Program Reference, Chapter 4, Sinclair Optics 1996. The format of the Zernike polynomials associated with this application are listed in Table 1.
  • According to a preferred aspect of the first embodiment, the inventive method comprises expressing at least one corneal surface as a linear combination of Zemike polynomials and thereby determining the resulting corneal wavefront Zernike coefficients, i.e. the coefficient of each of the individual Zernike polynomials that is selected for consideration. The lens is then modeled so that an optical system comprising of said model lens and cornea provides a wavefront having a sufficient reduction of selected Zernike coefficients. The method can optionally be refined with the further steps of calculating the Zernike coefficients of the Zernike polynomials representing a wavefront resulting from an optical system comprising the modeled intraocular lens and cornea and determining if the lens has provided a sufficient reduction of the wavefront Zernike coefficients of the optical system of cornea and lens; and optionally re-modeling said lens until a sufficient reduction in said coefficients is obtained. Preferably, in this aspect the method considers Zemike polynomials up to the 4th order and aims to sufficiently reduce Zernike coefficients referring to spherical aberration and/or astigmatism terms. It is particularly preferable to sufficiently reduce the 11th Zemike coefficient of a wavefront front from an optical system comprising cornea and said modeled intraocular lens, so as to obtain an eye sufficiently free from spherical aberration. Alternatively, the design method can also include reducing higher order aberrations and thereby aiming to reduce Zernike coefficients of higher order aberration terms than the 4th order.
  • When designing lenses based on corneal characteristics from a selected population, preferably the corneal surfaces of each individual are expressed in Zemike polynomials describing the surface topography and therefrom the Zernike coefficients of the wavefront aberration are determined. From these results average Zernike wavefront aberration coefficients are calculated and employed in the design method, aiming at a sufficient reduction of selected such coefficients. In an alternative method according to the invention, average values of the Zernike polynomials describing the surface topography are instead calculated and employed in the design method. It is to be understood that the resulting lenses arriving from a design method based on average values from a large population have the purpose of substantially improving visual quality for all users. A lens having a total elimination of a wavefront aberration term based on an average value may consequently be less desirable and leave certain individuals with an inferior vision than with a conventional lens. For this reason, it can be suitable to reduce the selected Zernike coefficients only to certain degree of the average value.
  • According to another approach of the inventive design method, corneal characteristics of a selected population and the resulting linear combination of polynomials, e.g. Zernike polynomials, expressing each individual corneal aberration can be compared in terms of coefficient values. From this result, a suitable value of the coefficients is selected and employed in the inventive design method for a suitable lens. In a selected population having aberrations of the same sign such a coefficient value can typically be the lowest value within the selected population and the lens designed from this value would thereby provide improved visual quality for all individuals in the group compared to a conventional lens. One embodiment of the method comprises selecting a representative group of patients and collecting corneal topographic data for each subject in the group. The method comprises further transferring said data to terms representing the corneal surface shape of each subject for a preset aperture size representing the pupil diameter. Thereafter a mean value of at least one corneal surface shape term of said group is calculated, so as to obtain at least one mean corneal surface shape term. Alternatively or complementary a mean value of at least one to the cornea corresponding corneal wavefront aberration term can be calculated. The corneal wavefront aberration terms are obtained by transforming corresponding corneal surface shape terms using a raytrace procedure. From said at least one mean corneal surface shape term or from said at least one mean corneal wavefront aberration term an ophthalmic lens capable of reducing said at least one mean wavefront aberration term of the optical system comprising cornea and lens is designed.
  • In one preferred embodiment of the invention the method further comprises designing an average corneal model for the group of people from the calculated at least one mean corneal surface shape term or from the at least one mean corneal wavefront aberration term. It also comprises checking that the designed ophthalmic lens compensates correctly for the at least one mean aberration term. This is done by measuring these specific aberration terms of a wavefront having traveled through the model average cornea and the lens. The lens is redesigned if said at least one aberration term has not been sufficiently reduced in the measured wavefront.
  • Preferably one or more surface descriptive (asphericity describing) constants are calculated for the lens to be designed from the mean corneal surface shape term or from the mean corneal wavefront aberration terms for a predetermined radius. The spherical radius is determined by the refractive power of the lens.
  • The corneal surfaces are preferably characterized as mathematical models and the resulting aberrations of the corneal surfaces are calculated by employing the mathematical models and raytracing techniques. An expression of the corneal wavefront aberrations is thereby obtained, i.e. the wavefront aberrations of a wavefront having passed such a corneal surface. Dependent on the selected mathematical model different routes to calculate the corneal wavefront aberrations can be taken. Preferably, the corneal surfaces are characterized as mathematical models in terms of a conoid of rotation or in terms of polynomials or a combination thereof. More preferably, the corneal surfaces are characterized in terms of linear combinations of polynomials.
  • In one embodiment of the invention, the at least one nonspheric surface of the lens is designed such that the lens, in the context of the eye, provides to a passing wavefront at least one wavefront aberration term having substantially the same value but with opposite sign to a mean value of the same aberration term obtained from corneal measurements of a selected group of people, to which said patient is categorized. Hereby a wavefront arriving from the cornea of the patient's eye obtains a reduction in said at least one aberration term provided by the cornea after passing said lens. The used expression ‘in the context of the eye’ can mean both in the real eye and in a model of an eye. In a specific embodiment of the invention, the wavefront obtains reduced aberration terms expressed in rotationally symmetric Zernike terms up to the fourth order. For this purpose, the surface of the ophthalmic lens is designed to reduce a positive spherical aberration term of a passing wavefront. The consequence of this is that if the cornea is a perfect lens and thus not will give rise to any wavefront aberration terms the ophthalmic lens will provide the optical system comprising the cornea and the ophthalmic lens with a negative wavefront spherical aberration term. In this text positive spherical aberration is defined such that a spherical surface with positive power produces positive spherical aberration. Preferably the lens is adapted to compensate for spherical aberration and more preferably it is adapted to compensate for at least one term of a Zernike polynomial representing the aberration of a wavefront, preferably at least the 11th Zemike term, see Table 1.
  • The selected groups of people could for example be a group of people belonging to a specific age interval, a group of people who will undergo a cataract surgical operation or a group of people who have undergone corneal surgery including but not limited to LASIK (laser in situ keratomileusis), RK (radial keratotomy) or PRK (photorefractive keratotomy). The group could also be a group of people who have a specific ocular disease or people who have a specific ocular optical defect.
  • The lens is also suitably provided with an optical power. This is done according to conventional methods for the specific need of optical correction of the eye. Preferably the refractive power of the lens is less than or equal to 30 diopters. An optical system considered when modeling the lens to compensate for aberrations typically includes the average cornea and said lens, but in the specific case it can also include other optical elements including the lenses of spectacles, or an artificial correction lens, such as a contact lens, a corneal inlay or an implantable correction lens depending on the individual situation.
  • In an especially preferred embodiment the ophthalmic lens is designed for people who will undergo a cataract surgery. In this case it is has been shown that the average cornea from such a population is represented by a prolate surface following the formula: z = ( 1 R ) r 2 1 + 1 - ( 1 R ) 2 ( cc + 1 ) r 2 + ad r 4 + ae r 6
    wherein,
    • (i) the conical constant cc has a value ranging between −1 and 0
    • (ii) R is the central lens radius and
    • (iii) ad and ae are aspheric polynomial coefficients additional to the conical constant.
  • In these studies the conic constant of the prolate surface ranges between about −0.05 for an aperture size (pupillary diameter) of 4 mm to about −0.18 for an aperture size of 7 mm. Accordingly an ophthalmic lens suitable to improve visual quality by reducing at least spherical aberration for a cataract patient based on an average corneal value will have a prolate surface following the formula above. Since cornea generally produces a positive spherical aberration to a wavefront in the eye, an ophthalmic lens for implantation into the eye will have negative spherical aberration terms while following the mentioned prolate curve. As will discussed in more detail in the exemplifying part of the specification, it has been found that an intraocular lens that can correct for 100% of a mean spherical aberration has a conical constant (cc) with a value of less than 0 (representing a modified conoid surface), with an exact value dependent on the design pupillary diameter and the selected refractive power. For example, a 6 mm diameter aperture will provide a 22 diopter lens with conical constant value of about −1.03. In this embodiment, the ophthalmic lens is designed to balance the spherical aberration of a cornea that has a Zernike polynomial coefficient representing spherical aberration of the wavefront aberration with a value in the interval from 0.000156 mm to 0.001948 mm for a 3 mm aperture radius, 0.000036 mm to 0.000448 mm for a 2 mm aperture radius, 0.0001039 mm to 0.0009359 mm for a 2.5 mm aperture radius and 0.000194 mm to 0.00365 mm for a 3.5 mm aperture radius using polynomials expressed in OSLO format. These values were calculated for a model cornea having a single surface with a refractive index of the cornea of 1.3375. It is possible to use optically equivalent model formats of the cornea without departing from the scope of the invention. For example multiple surface corneas or corneas with different refractive indices could be used. The lower values in the intervals are here equal to the measured average value for that specific aperture radius minus one standard deviation. The higher values are equal to the measured average value for each specific aperture radius plus three standard deviations. The used average values and standard deviations are shown in tables 8,9,10 and 11. The reason for selecting only minus one SD (=Standard Deviation) while selecting plus three SD is that in this embodiment it is convenient to only compensate for positive corneal spherical aberration and more than minus one SD added to the average value would give a negative corneal spherical aberration.
  • According to one embodiment of the invention the method further comprises the steps of measuring the at least one wavefront aberration term of one specific patient's cornea and determining if the selected group corresponding to this patient is representative for this specific patient. If this is the case the selected lens is implanted and if this is not the case a lens from another group is implanted or an individual lens for this patient is designed using this patients corneal description as a design cornea. These method steps are preferred since then patients with extreme aberration values of their cornea can be given special treatments.
  • According to another embodiment, the present invention is directed to the selection of an intraocular lens of refractive power, suitable for the desired optical correction that the patient needs, from a plurality of lenses having the same power but different aberrations. The selection method is similarly conducted to what has been described with the design method and involves the characterizing of at least one corneal surface with a mathematical model by means of which the aberrations of the corneal surface is calculated. The optical system of the selected lens and the corneal model is then evaluated so as to consider if sufficient reduction in aberrations is accomplished by calculating the aberrations of a wavefront arriving from such a system. If an insufficient correction is found a new lens is selected, having the same power, but different aberrations. The mathematical models employed herein are similar to those described above and the same characterization methods of the corneal surfaces can be employed.
  • Preferably, the aberrations determined in the selection are expressed as linear combinations of Zemike polynomials and the Zernike coefficients of the resulting optical system comprising the model cornea and the selected lens are calculated. From the coefficient values of the system, it can be determined if the intraocular lens has sufficiently balanced the corneal aberration terms, as described by the Zernike coefficients of the optical system. If no sufficient reduction of the desired individual coefficients are found these steps can be iteratively repeated by selecting a new lens of the same power but with different aberrations, until a lens capable of sufficiently reducing the aberrations of the optical system is found. Preferably at least 15 Zernike polynomials up to the 4th order are determined. If it is regarded as sufficient to correct for spherical aberration, only the spherical aberration terms of the Zernike polynomials for the optical system of cornea and intraocular lens are corrected. It is to be understood that the intraocular lens shall be selected so a selection of these terms become sufficiently small for the optical system comprising lens and cornea. In accordance with the present invention, the 11th Zernike coefficient, a11, can be substantially eliminated or brought sufficiently close to zero. This is a prerequisite to obtain an intraocular lens that sufficiently reduces the spherical aberration of the eye. The inventive method can be employed to correct for other types of aberrations than spherical aberration by considering other Zernike coefficients in an identical manner, for example those signifying astigmatism, coma and higher order aberrations. Also higher order aberrations can be corrected dependent on the number of Zernike polynomials elected to be a part of the modeling, in which case a lens can be selected capable of correcting for higher order aberrations than the 4th order.
  • According to one important aspect, the selection method involves selecting lenses from a kit of lenses having lenses with a range of power and a plurality of lenses within each power having different aberrations. In one example the lenses within each power have anterior surfaces with different aspherical components. If a first lens does not exhibit sufficient reduction in aberration, as expressed in suitable Zernike coefficients, then a new lens of the same power, but with a different surface (aspheric component) is selected. The selection method can if necessary be iteratively repeated until the best lens is found or the studied aberration terms are reduced below a significant borderline value. In practice, the Zernike terms obtained from the corneal examination will be directly obtained by the ophthalmic surgeon and by means of an algorithm they will be compared to known Zernike terms of the lenses in the kit. From this comparison the most suitable lens in the kit can be found and implanted. Alternatively, the method can be conducted before cataract surgery and data from the corneal estimation is sent to a lens manufacturer for production of an individually tailored lens.
  • The present invention further pertains to an intraocular lens having at least one nonspherical surface capable of transferring a wavefront having passed through the cornea of the eye into a substantially spherical wavefront with its center at the retina of the eye. Preferably, the wavefront is substantially spherical with respect to aberration terms expressed in rotationally symmetric Zernike terms up to the fourth order.
  • In accordance with an especially preferred embodiment, the invention relates to an intraocular lens, which has at least one surface, when expressed as a linear combination of Zernike polynomial terms using the normalized format, that has a negative 11th term of the fourth order with a Zernike coefficient a11 that that can balance a positive such term of the cornea to obtain sufficient reduction of the spherical aberration of the eye after implantation. In one aspect of this embodiment, the Zernike coefficient a11 of the lens is determined so as to compensate for an average value resulting from a sufficient number of estimations of the Zernike coefficient al in several corneas. In another aspect, the Zernike coefficient a11 is determined to compensate for the individual corneal coefficient of one patient. The lens can accordingly be tailored for an individual with high precision.
  • The invention further relates to another method of providing a patient with an intraocular lens, which at least partly compensates for the aberrations of the eye. This method comprises removing the natural lens from the eye. Surgically removing the impaired lens can be performed by using a conventional phacoemulsification method. The method further comprises measuring the aberrations of the aphakic eye, not comprising a lens, by using a wavefront sensor. Suitable methods for wavefront measurements are found in J.Opt.Soc.Am., 1994, Vol. 11(7), pp. 1949-57 by Liang et. al. Furthermore, the method comprises selecting from a kit of lenses a lens that at least partly compensates for the measured aberrations and implanting said lens into the eye. The kit of lenses comprises lenses of different power and different aberrations and finding the most suitable lens can be performed in a manner as earlier discussed. Alternatively, an individually designed lens for the patient can be designed based on the wavefront analysis of the aphakic eye for subsequent implantation. This method is advantageous, since no topographical measurements of the cornea are and the whole cornea, including the front and back surfaces, is automatically considered.
  • The lenses according to the present invention can be manufactured with conventional methods. In one embodiment they are made from soft, resilient material, such as silicones or hydrogels. Examples of such materials suitable for foldable intraocular lenses are found in U.S. Pat. No. 5,444,106 or in U.S. Pat. No. 5,236,970. Manufacturing of nonspherical silicone lenses or other foldable lenses can be performed according to U.S. Pat. No. 6,007,747. Alternatively, the lenses according to the present invention can be made of a more rigid material, such as poly(methyl)methacrylate. The skilled person can readily identify alternative materials and manufacturing methods, which will be suitable to employ to produce the inventive aberration reducing lenses.
  • DETAILED DESCRIPTION OF THE INVENTION
  • FIG. 1 shows a comparison of the a11 (“Z11”) Zernike coefficient values for 10 subjects if implanted with CeeOn® 911 lenses and the inventive averaged (“Z11”) lens.
  • FIG. 2 shows modeled visual acuities of the test subjects with CeeOn® 911 lenses and the inventive averaged (“Z11”) lenses.
  • FIG. 3 and FIG. 4 show modulation transfer function comparisons between CeeOn® 911 lenses and the inventive averaged (“Z11”) lenses
  • FIG. 5 shows visual acuity plotted as a function of the astigmatism of the lenses according to the model lenses according to the invention.
  • FIG. 6 shows the best corrected visual acuity with the inventive lenses.
  • FIG. 7 and 8 show modulation transfer functions of an individual with an individually designed lens.
  • FIG. 9 shows the best corrected visual acuity with individually designed lenses according to the invention.
  • FIG. 10 shows the age distribution of 71 patients used in a study described below in the example part.
  • FIG. 11 shows a height map given by an Orbscan® true height data file.
  • FIG. 12 shows average corneal wavefront aberration coefficients.
  • FIG. 13 shows a scatter plot of the spherical aberration of 71 subjects for a 6 mm diameter aperture.
  • FIG. 14 shows a scatter plot of the spherical aberration of 71 subjects for a 4 mm diameter aperture.
  • FIG. 15 shows a scatter plot of the spherical aberration of 71 subjects for a 5 mm diameter aperture.
  • FIG. 16 shows a scatter plot of the spherical aberration of 71 subjects for a 7 mm diameter aperture.
  • EXAMPLE 1
  • A sample set of 10 corneal surfaces from individuals were described using Zernike polynomials. The sag data of the corneas was determined using the real height data measured with a Humphrey Atlas corneal topographer. The corneal topographer measures the height (zi) at a discrete number of points. The corneal surface can then be expressed as a linear combination of the first 15 Zemike polynomials (as described in Equation 1, above), where Zi is the ith Zemike polynomial and ai is the weighting coefficient for this polynomial. The Zemike polynomials are a set of complete orthogonal polynomials defined on a unit circle. These polynomials as listed in Table 1 above and the weighting coefficients (ai) are calculated from the height data using a Grahm-Schmidt orthogonalization procedure. The Zernike coefficients (ai) for the 10 sample corneas are listed in Table 2 in mm.
    TABLE 2
    The Zernike coefficients for the 10 individual corneal surfaces in mm.
    ACH ASA CGR CNR FCA FCM FCZ FGP JAE JBH
    a1 −7.713337 −6.698643 −7.222353 −7.169027 −7.001356 −7.322624 −7.03713 −7.84427 −7.582005 −6.890056
    a2 0.000271 −0.000985 0.000386 −0.000519 0.000426 −0.000094 −0.000236 −0.00056 −0.000344 −0.000155
    a3 0.000478 −0.000002 −0.000847 0.000996 −0.000393 0.000045 0.000454 0.000347 0.000246 −0.000558
    a4 0.073309 0.083878 0.077961 0.078146 0.080111 0.077789 0.079987 0.072595 0.075803 0.081415
    a5 −0.000316 −0.000753 0.000119 0.000347 −0.001197 0.00022 −0.000071 0.000686 −0.000388 −0.000269
    a6 0.001661 0.000411 −0.000148 −0.000386 0.000314 0.000669 0.00079 −0.00048 0.001688 0.001492
    a7 0.000193 0.00006 −0.000295 0.000324 −0.000161 −0.000058 0.000148 0.00014 0.000104 −0.000227
    a8 0.000098 −0.000437 0.000146 −0.00018 0.000147 0.000039 −0.000076 −0.00025 −0.000173 −0.000116
    a9 −0.000091 −0.000168 −0.000107 0.000047 −0.000181 −0.000154 −0.000043 0.000092 −0.000023 −0.000109
    a10 −0.000055 0.000139 −0.000132 −0.000149 0.000234 −0.000228 0.000244 −8.2E−05 −0.000004 0.000065
    a11 0.000277 0.000394 0.000203 0.000305 0.000285 0.000315 0.000213 0.000308 0.000309 0.0004
    a12 −0.000019 −0.000105 0.000025 0.00007 −0.000058 −0.000033 0.00009   −2E−06 −0.000115 −0.00011
    a13 0.000048 0.000032 0.000085 0.000017 0.000039 0.000059 0.000022 0.000101 −0.000042 −0.000052
    a14 −0.000067 0.000041 −0.000081 −0.000049 0.000118 −0.000108 0.000127 −1.9E−05 −0.000068 0.00001
    a15 −0.000048 −0.000075 −0.000073 −0.000019 −0.000036 −0.000119 −0.000021 0.000022 −0.000013 −0.000048
  • These wavefront aberration coefficients can be calculated using optical design software such as OSLO (Sinclair Optics). Table 3 shows the results of calculating the wavefront aberration for subject FCM. (N.B. The normalization factor for the polynomials used in OSLO is different from those shown in Table 3. This difference has been incorporated into the coefficient values.)
    TABLE 3
    The corneal aberration coefficients in mm calculated for subject
    FCM using OSLO(N.B. OSLO numbering order)
    Aberration Coefficients for FCM (OSLO)
    A0 −0.000123
    A1 4.5960e−07
    A2 2.0869e−07
    A3 −5.355e−06
    A4 0.000551
    A5 0.000182
    A6 3.7296e−05
    A7 −5.5286e−05 
    A8 0.000116
    A9 −0.000217
    A10 −0.000147
    A11 −3.8151e−05 
    A12 6.1808e−05
    A13 −3.3056e−07 
    A14  4.888e−07
    A15 −1.8642e−06 
    A16 −0.000115
    A17 −0.000127
  • Example 2
  • An averaged design embodiment of the inventive lenses has been calculated using the average “old” cornea information provided by Pablo Artal, Murcia, Spain. This data was taken from a population sample of 16 old corneas in which all of the subjects had a visual acuity of 20/30 or better. The corneal surfaces were described using Zernike polynomials for an aperture of 2.0 mm radius (ro). The polynomial coefficients were then used to determine the radius and asphericity values using Equations 2 and 3. R = r o 2 2 ( 2 3 a 4 - 6 5 a 11 ) ( 2 ) K 2 = 8 R 3 r o 4 6 5 a 11 ( 3 )
  • Note that the asphericity constant, K, describes the surface's variation from a sphere (K2=1-e2). (i.e. For a sphere K=1 and for a parabola K=0). (cc=K2-1, wherein cc is the conical constant)
  • Because the cornea surface has only been described for a central diameter of 4 mm, the calculated R and K are also only accurate over the central 4 mm. A pupil size of 4.0 mm is therefore selected for design purposes. This pupil size is reasonable for intraocular lens design purposes.
  • A 22D CeeOn® 911 lens from Pharmacia Corp was chosen as a starting point for the averaged lens design. For the purpose of comparison, the averaged lenses were also designed to be 22D. (Note that other dioptres would give similar simulation results, provided that the spherical surfaces of the lenses is the same.) The surface information for the starting point eye model is summarized in Table 4. In the conical and asherical data demonstrated in Table 4, the average conic constant CC is determined for the 10 individual corneas of Example 1.
    TABLE 4
    Surface data for the starting point of the averaged (“Z11”) design
    Radius Thickness Aperture Conic Refractive
    Surface # (mm) (mm) Radius (mm) Constant Index
    Object 2.272611 1.0
    1 7.573 3.6 2.272611 −0.0784* 1.3375
    (cornea)
    2 (pupil) 2.0 1.3375
    3 0.9 2.0 1.3375
    4 (lens 11.043 1.14 3.0 1.4577
    1)
    5 (lens −11.043 17.2097 3.0 1.336
    2)

    *This conic constant for the “average” cornea is taken from the published works of Guirao and Artal
  • The wavefront aberration coefficients in mm for the average cornea are shown in column 1 of Table 5, while the coefficients in mm of the combination of the average cornea and the 911 lens are shown in column 2 of Table 5. Note that the Z11 coefficient (a11) of the average old cornea alone is 0.000220 mm, while the Z11 of this eye implanted with a 911 would be 0.000345 mm.
    TABLE 5
    Zernike coefficients in mm of the average cornea and the starting
    point for design (Average cornea + 911)
    Average Cornea Average Cornea + 911
    a1 0.000432 0.000670
    a2 0.0 0.0
    a3 0.0 0.0
    a4 0.000650 0.00101
    a5 0.0 0.0
    a6 0.0 0.0
    a7 0.0 0.0
    a8 0.0 0.0
    a9 0.0 0.0
    a10 0.0 0.0
    a11 0.000220 0.000345
    a12 0.0 0.0
    a13 0.0 0.0
    a14 0.0 0.0
    a15 0.0 0.0
  • The averaged lens was optimized to minimize spherical aberration, while maintaining a 22D focal power. The lens material remained the same as in the 22D 911 lens (MRI silicone, the refractive index of which is 1.45 in 77 at 37° C. The resulting design for an equiconvex lens is The averaged lens was optimized to minimize spherical aberration, while maintaining a 22D focal power. The lens material remained the same as in the 22D 911 lens (HRI silicone, the refractive The resulting design for an equiconvex lens is provided in Table 6. The total-eye Z11 coefficient of the average cornea combined with this lens is −2.42×10−7 mm(versus 0.000345 mm for the cornea plus 911 lens).
    TABLE 6
    Surface data for the starting point of the averaged lens design
    4th Order 6th Order
    Radius Thickness Aperture Conic Aspheric Aspheric Refractive
    Surface # (mm) (mm) Radius (mm) Constant Constant Constant Index
    Object 2.272611 1.0
    1 (cornea) 7.573 3.6 2.272611 −0.0784 1.3375
    2 (pupil) 2.0 1.3375
    3 0.9 2.0 1.3375
    4 (lens 1) 10.0 1.02 3.0 −2.809 −0.000762 −1.805e−05 1.4577
    5 (lens 2) −12.0 17.2097 3.0 1.336
  • The corneas of the 10 test subjects were combined in an optical system with both the 911 and the averaged lenses. The resulting total-eye Z11 coefficients are shown in FIG. 1. As demonstrated, in FIG. 1, in each case, the absolute value of the Z11 coefficient was less when the Z11 lens was implanted. Because subjects CGR and FCZ have relatively low levels of corneal spherical aberration to begin with, the total-eye spherical aberration is overcorrected in these two cases. As a result, the sign of the total spherical aberration is noticeably reversed in these two cases, and the amount of spherical aberration is still significant. In every other case, the spherical aberration of the total eye would be essentially 0 after the implantation of a Z11 lens. The visual acuity of each of the 10 test subjects were calculated according to standard methods described in “Visual acuity modeling using optical raytracing of schematic eyes”, Greivenkamp et al., American journal of ophthalmology, 120(2), 227-240, (1995), for the implantation of both a 22D 911 lens and a 22D averaged “Z11” lens. The square wave responses were calculated using OSLO™ and a software module was written in Matlab™ to calculate the visual acuity following the above method. The resulting visual acuities are shown in FIG. 2. Out of the 10 cases investigated and shown in FIG. 2, eight subjects had better vision when implanted with the averaged lens according to the present invention. In the cases where the visual acuity decreased their Snellen distance increased by less than 1 ft which would not show up in visual acuity testing.
  • To be able to assess the optical quality difference between a CeeOn® 911A and averaged lenses according to the present invention, a physical model of the average cornea was designed and manufactured. It is a convex-plano lens of PMMA with an aspheric front surface having a value of 0.000218 for Zernike coefficient al 1. This value is almost equal to the value of the calculated average cornea: 0.000220. With the PMMA model cornea MTF measurements were performed on an optical bench in a model eye with the “averaged” Z11 lenses and CeeOn® 911A lenses. Modulation Transfer Function (MTF) measurements are a widely accepted method of quantifying image quality. Through focus MTF measurements at 50 c/mm and a frequency MTF curves focussed at 50 c/mm, in both cases with a 3 mm pupil are shown in the FIG. 3 and FIG. 4, respectively for lenses with an optical power of 20D. The width of the through focus MTF at 0.2 MTF units is a measure for the depth of focus and is equal for both lenses. The MTF curve focussed at 50 c/mm for “averaged” Z11 lenses is almost diffraction limited and is better than that for CeeOn 911A lenses.
  • The astigmatism of the cornea and the defocus of the system can be corrected by adjusting the Zernike coefficients of the cornea model and the focal position of the system. When this is done and the procedure for calculating visual acuity is repeated the results in FIG. 6 are obtained. They represent a modeled best corrected visual acuity. We now see that, in all cases, after correction for astigmatism and defocus (as in reality would be done with spectacles) the inventive averaged lens produces a higher best corrected visual acuity than the 911 lens of the same dioptre.
  • Example 3
  • Individually Designed Lenses:
  • As a potential further improvement upon the averaged lens (“Z11 lenses”), an individualized lens (“I11 lenses”) was designed for each of four subject corneas employing the same design principles as demonstrated in Example 2. The individual lenses were designed such that the Z11 of the lens balances the Z11 of the individual cornea. The total-eye Z11 coefficients for the I11 lenses are shown in Table 7, together
    TABLE 7
    The Z11 coefficients in mm of the model eyes with the
    911, Z11 and I11 lenses
    Subject 911 averaged individual
    CGR 0.000107 −0.000101 −0.000004
    FCZ 0.000105 −0.000100 −0.000005
    JAE 0.000195 −0.000016 −0.000012
    JBH 0.000238 0.000037 −0.000019

    with the corresponding coefficients for the 911 and the averaged lenses. Furthermore, for each of the 911, Z11 (averaged), and I11 (individual) lenses, the MTF curve at best focussed at 50 c/mm and the through focus MTF at 50 c/mm for subject JAE are plotted below in FIG. 7 and 8. From FIG. 7 and 8, it is seen that the MTF at 50 c/mrn of eyes implanted with the Z11 and I11 lenses is higher than the MTF of the same eyes implanted with 911 lenses. It can also be seen that the through focus MTF of all of the lenses is satisfactory. The Z 11 has as much depth of focus as the 911. However, it is also interesting to note that the I11 does not provide a significant improvement in either MTF or through focus MTF, relative to the Z11 lens.
  • The visual acuities of the subjects with individualized lenses have also been calculated. FIG. 9 compares these acuities with the visual acuity calculated for the 911 and Z11 lenses.
  • From FIG. 9, we see that for all 4 subjects, visual acuity is better for both the Z11 and I11 lenses than it is for the 911 lens. We also see that the results with the Z11 and I11 lenses do not differ significantly—the average cornea is relatively accurate for each of the 4 test subjects.
  • Example 4
  • The design of an ophthalmic lens, which is adapted to reduce the spherical aberration of an average cornea obtained from a group of people will be described in detail here below. The lens will be called the Z11. lens because it compensates for the normalized 11th Zernike term describing spherical aberration of the corneas. It was decided to use a population of potential recipients of the Z11 lens, namely cataract patients.
  • Description of the Population:
  • The population included 71 cataract patients from St. Erik's eye hospital in Stockholm, Sweden. These patients were of ages ranging from 35 to 94 years (as of Apr. 12, 2000). The average age of our population was 73.67 years. A histogram of the age of the population is shown in FIG. 10.
  • The corneas of the 71 subjects were measured using an Orbscan® (Orbtek, Salt Lake City) device. Orbscan® is a scanning slit-based, corneal and anterior segment topographer that measures both surfaces of the cornea, as well as the anterior lens surface and the iris. Each surface can be displayed as maps of elevation, inclination, curvature, and power.
  • Fitting Algorithm:
  • The corneal elevation height data (the Cartesian locations of points on the surface of the cornea) for the anterior surface was obtained using the Orbscan®, and used as raw data for the determination of the optical properties of the cornea. The height data from an example Orbscan® file is represented in FIG. 11.
  • The Cartesian co-ordinates representing the elevation height data are transformed to polar co-ordinates (x,y,z→r,θ,z). In order to describe the surface, this data is then fit to a series of polynomials as described in Equation lb. The coefficients (a's), or weighting factors, for each polynomial are determined by the fitting procedure resulting in a complete description of the surface. The polynomials (Zi) used are the normalized Zernike polynomials. z ( ρ , θ ) = i = 1 L a i Z i ( 1 b )
  • These polynomials are special because they are orthonormal over a continuous unit circle. They are commonly used to describe wavefront aberrations in the field of optics. Corneal topographers measure the elevation heights at a discrete number of points. The Zemike polynomials are not orthogonal over a discrete set of points. However, applying an orthogonalization procedure, termed Gram-Schmidt orthogonalization, to the height data, allows the data to be fit in terms of Zernike polynomials maintaining the advantages of an orthogonal fit. Sixty-six coefficients (a's) were used to fit the height data provided by the Orbscan® software. A Matlab™ algorithm was used in the fitting procedure. The radius and asphericity value can be approximated from the Zernike coefficients (Equations 2b and 3b) and the conic constant of the surface is simply K2-1 (from this we know that for a sphere K2=1). The fitting procedure is well described in a number of references. Four different articles are refereed to here: “Wavefront fitting with discrete orthogonal polynomials in a unit radius circle”, Daniel Malacara, Optical Engineering, June 1990, Vol. 29 No. 6, “Representation of videolceratoscopic height data with Zernike polynomials”, J. Schwiegerling, J. Greivenkamp and J. Miller, JOSA A, October 1995, Vol. 12 No. 10, “Wavefront interpretation with Zernike polynomials” J. W. Wang and D. E. Silva, Applied Optics, May 1980, Vol. 19, No. 9 and “Corneal wave aberration from videokeratography: accuracy and limitations of the procedure”, Antonio Guirao and Pablo Artal, J Opt Soc Am A Opt Image Sci Vis June 2000, Vol. 17(6):955-65. R = r pupil 2 2 ( 2 3 a 4 - 6 5 a 11 ) ( 2 b ) K sq = 8 R 3 r o 4 6 5 a 11 ( 3 b )
    Calculation of Wavefront Aberration:
  • Knowing the shape of the anterior corneal surface (Zernike coefficients described above as a's), it is possible to determine the wavefront aberration contributed by this surface using a raytrace procedure. This is described in for example “Corneal wave aberration from videokeratography: accuracy and limitations of the procedure”, Antonio Guirao and Pablo Artal, J Opt Soc Am A Opt Image Sci Vis Jun 2000, Vol. 17(6):955-65.
  • Results:
  • Average Corneal Spherical Aberration and Shape:
  • The 71 subjects were evaluated using the criteria described above for a 6 mm aperture. The wavefront aberration of each subject was determined after fitting the surface elevation with Zernike polynomials. FIG. 12 shows that average and standard deviation of each Zernike term (normalized format). The error bars represent ±1 standard deviation. There are three aberrations that are significantly different from zero on average in our population. These are astigmatism (A5), coma (A9) and spherical aberration (A11). Spherical aberration is the only rotationally symmetric aberration, making it the only aberration that can be corrected with a rotationally symmetric IOL.
  • FIG. 13 shows a scatter plot of the value of the Zernike coefficient (OSLO format) representing spherical aberration for each of the 71 subjects before cataract surgery. The solid line in the middle represents the average spherical aberration, while the dotted lines represent +1 and −1 standard deviation. Table 8 lists the average, standard deviation, maximum and minimum values for the radius, aspheric constant, spherical aberration and root mean square error.
    TABLE 8
    the average, standard deviation, maximum and minimum values
    for the radius, aspheric constant, spherical aberration and root
    mean square error for a 6 mm aperture.
    Standard
    Average Value Deviation Maximum Minimum
    R (mm) 7.575 0.333 8.710 7.072
    Ksq 0.927 0.407 2.563 0.0152
    SA coefficient 0.000604 0.000448 0.002003 −0.000616
    OSLO format (in
    mm)
    RMSE 0.000055 0.00000482 0.000069 0.000045
  • Tables 9, 10 and 11 below show the corresponding results for aperture sizes of 4, 5 and 7 mm respectively. FIG. 14, 15 and 16 are the corresponding scatter plots.
    TABLE 9
    The average, standard deviation, maximum and minimum values
    for the radius, aspheric constant, spherical aberration and root
    mean square error using an aperture diameter of 4 mm.
    Average Value Standard Deviation Maximum Minimum
    R 7.56292  0.320526 8.688542 7.067694
    Ksq 0.988208 0.437429 2.33501 −0.051091
    SA (A11 0.000139 0.000103 0.00041 −0.000141
    in mm)
    RMSE 4.52E−05 4E−06 0.000054 0.000036
  • TABLE 10
    The average, standard deviation, maximum and minimum values
    for the radius, aspheric constant, spherical aberration and root
    mean square error using an aperture diameter of 5 mm.
    Average
    Value Standard Deviation Maximum Minimum
    R 7.55263   0.320447 8.714704 7.09099
    Ksq 0.945693  0.364066 2.045412 0.044609
    SA 0.00031189 0.000208 0.000793 −0.000276
    (A11 in mm)
    RMSE 4.7E−05 4.02E−06 0.000057 0.000037
  • TABLE 11
    The average, standard deviation, maximum and minimum values
    for the radius, aspheric constant, spherical aberration and root
    mean square error using an aperture diameter of 7 mm.
    Average
    Value Standard Deviation Maximum Minimum
    R 7.550226 0.336632 8.679712 7.040997
    Ksq 0.898344 0.416806 2.655164 −0.04731
    SA 0.001058 0.000864 0.003847 −0.001319
    (A11 in mm)
    RMSE 7.58E−05 1.02E−05 0.000112 0.000057

    Design Cornea:
  • One model cornea was designed and each Z11 lens power was designed using this cornea. The cornea was designed so that it had a spherical aberration that is the same as the average calculated for the population. The design cornea radii and aspheric constants are listed in Table 12 for different aperture sizes. In every case, the radius of curvature was taken to be the average radius determined from the Zernike fit data. The aspheric constant was varied until the spherical aberration value of the model cornea was equal to the average spherical aberration value for the population.
    TABLE 12
    The design cornea radii and aspheric constants for
    aperture diameters of 4, 5, 6, and 7 mm.
    Aperture Conic Constant Z11
    size (mm) Radius (mm) (OSLO value, K2 − 1) Coefficient (mm)
    4 7.563 −0.0505 0.000139
    5 7.553 −0.1034 0.000312
    6 7.575 −0.14135 0.000604
    7 7.55 −0.1810 0.001058
  • As discussed previously, the 6 mm aperture diameter values are used for the design cornea. This choice enables us to design the Z11 lens so that it has no spherical aberration (when measured in a system with this cornea) over a 5.1 mm lens diameter. The OSLO surface listing for the Z11 design cornea is listed in Table 13. The refractive index of the cornea is the keratometry index of 1.3375.
  • These values were calculated for a model cornea having a single surface with a refractive index of the cornea of 1.3375. It is possible to use optically equivalent model formats of the cornea without departing from the scope of the invention. For example multiple surface corneas or corneas with different refractive indices could be used.
    TABLE 13
    OSLO surface listing for the Z11 design cornea.
    Aperture Conic
    Surface Radius Thickness Radius Constant Refractive
    # (mm) (mm) (mm) (cc) index
    Object 1.0000e+20 1.0000e+14 1.0
    1 7.575000 3.600000 3.000003 −0.141350 1.3375
    (cornea)
    2 2.640233 1.3375
    (pupil)
    3 0.900000 2.64023 1.3375
    4 25.519444 2.550292 1.3375
    5 2.2444e−05 1.3375

    Lens Design:
  • Each Z11 lens was designed to balance the spherical aberration of the design cornea. The starting point for design was the CeeOn Edge© 911 lens described in U.S. Pat. No. 5,444,106 of the same power, with modified edge and center thickness. The lens was then placed 4.5 mm from the anterior corneal surface. The distance from the anterior corneal surface is not that critical and could be varied within reasonable limits. The surface information for the starting point eye model for the 22D lens design process is listed in Table 14. The anterior surface of the lens was described using the formula shown in Equation 4. The variables cc, ad and ae were modified to minimize the spherical aberration. The variables are determined for an aperture size of 5.1 mm and the surface is extrapolated from these values to the optical aperture size of 6 mm. The resulting 22D Z11 eye model is listed in Table 15. The anterior surface of this 22D lens has been modified in such a way that the spherical aberration of the system (cornea+lens) is now approximately equal to 0. The wavefront aberration coefficients as calculated by OSLO for the CeeOn Edge 911 22D lens eye model and the 22D Z11 lens eye model are listed below in Table 16. Note that the coefficient representing spherical aberration for the starting point eye model is 0.001005 mm for a 6 mm diameter aperture placed at the cornea, while the same coefficient for the eye model with the designed Z11 lens is −1.3399e-06 mm. The same process as described above for a 22D lens can similarly be performed for any other lens power. z = ( 1 R ) r 2 1 + 1 - ( 1 R ) 2 ( cc + 1 ) r 2 + ad r 4 + ae r 6 ( 4 )
    TABLE 14
    Surface data for the starting point averaged eye model and a 22D lens
    Aperture Conic
    Radius Thickness Radius Constant Refractive
    Surface # (mm) (mm) (mm) (cc) index
    Object 1.0000e+20 1.0000e+14 1.0
    1 (cornea) 7.575 3.600000 3.000003 −0.14135 1.3375
    2 (pupil) 2.640233 1.336
    3 0.900000 2.64023 1.336
    4 (lens) 11.043 1.164 2.550191 1.458
    5 (lens) −11.043 17.1512 2.420989 1.336
    6 (image) 0.0 −0.417847 0.058997
  • TABLE 15
    Surface data for the averaged eye model and the final 22D Z11 lens
    Aperture Conic
    4th Order 6th Order
    Radius Thickness Radius Constant aspheric aspheric Refractive
    Surface # (mm) (mm) (mm) (cc) Constant constant index
    Object 1.0e+20 1.00e+14 1.0
    1 7.575 3.60 3.00 −0.14135 1.3375
    (cornea)
    2 2.64 1.336
    (pupil)
    3 0.90 2.64 1.336
    4 (lens) 11.043 1.164 2.55 −1.03613 −0.000944 −1.37e−05 1.458
    5 (lens) −11.043 17.1512 2.42 1.336
    6 (image) 1.59e−05
  • TABLE 16
    Zernike coefficients (OSLO format) for the average cornea and
    a 22D 911 lens and the average cornea and the 22D Z11 lens
    Coefficient Average cornea + 22D 911 Average cornea + 22D Z11
    a1 −0.000962  −1.896e−06
    a2 0.0 0.0
    a3 0.0 0.0
    a4 2.3101e−05 −3.9504e−06
    a5 0.0 0.0
    a6 0.0 0.0
    a7 0.0 0.0
    a8 0.0 0.0
    a9 0.00105 −1.3399e−06
    a10 0.0 0.0
    a11 0.0 0.0
    a12 0.0 0.0
    a13 0.0 0.0
    a14 0.0 0.0
    a15 0.0 0.0
  • The optical form chosen for the new Z11 design is an equiconvex lens made from a silicone with refractive index of 1.458. The spherical aberration of an average cornea is balanced by the Z11 lens yielding a system without spherical aberration. The front surface of the lens is modified such that the optical path lengths of all on-axis rays within the design aperture are the same producing a point focus. This feature can be achieved with many lens forms. The Z11 lens could therefore be designed on a convex-plano, plano-convex, non-equiconvex lens or any other design yielding a positive lens. The Z11 concept could also be extended in order to encompass a negative lens used to correct the refractive errors of the eye. The front surface or back surface could also be modified to produce the needed change in optical path difference that neutralizes the spherical aberration. There are therefore many possible designs that would achieve the goals of the Z11 lens design.

Claims (23)

1. A method of performing visual correction in a patient by implanting an intraocular lens, comprising:
(i) determining a spherical aberration of a cornea of an eye by measuring at least one surface of the cornea;
(ii) modeling an intraocular lens having an aspheric surface comprising a radius and a conic constant; and
(iii) based on the spherical aberration, selecting the radius and the conic constant to at least partially compensate for the spherical aberration.
2. The method of claim 1, further comprising characterizing the at least one surface as a mathematical model and using the measurement to determine the spherical aberration.
3. The method of claim 1, wherein modeling of the intraocular lens comprises selecting of at least one lens parameter of the intraocular lens, the at least one lens parameter including at least one of an anterior radius, an anterior shape, a posterior radius, a posterior shape, a lens thickness, and a refractive index.
4. The method of claim 3, wherein at least one of the shapes deviates from a sphere.
5. The method of claim 1, wherein the cornea is a model cornea of a model eye.
6. The method of claim 5, wherein the model cornea is produced by measuring the corneas of a population.
7. The method of claim 6, wherein the spherical aberration is an average corneal spherical aberration of the population.
8. The method of claim 6, wherein the population includes people of a specific age group, people with a cataract, people who have received a corneal ablative procedure, people who are candidates for a corneal ablative procedure, and/or people who are highly myopic or highly hyperopic.
9. The method of claim 1, wherein measuring at least one surface of the cornea comprises characterizing at least a front corneal surface of an individual by means of a topographical measurement.
10. A method of performing visual correction in a patient by implanting an intraocular lens, comprising:
(i) determining an aberration of a cornea of an eye by measuring a surface of the cornea;
(ii) modeling an intraocular lens; and
(iii) based on the aberration of the cornea, selecting a spherical aberration of the intraocular lens to at least partially compensate for the aberration of the cornea.
11. The method of claim 10, wherein selecting the spherical aberration of the intraocular lens comprises selecting a conic constant of at least one surface of the intraocular lens.
12. The method of claim 10, wherein modeling of the intraocular lens comprises selecting of at least one lens parameter of the intraocular lens, the at least one lens parameter including at least one of an anterior radius, an anterior shape, a posterior radius, a posterior shape, a lens thickness, and a refractive index.
13. The method of claim 12, wherein at least one of the shapes deviates from a sphere.
14. The method of claim 10, wherein the cornea is a model cornea of a model eye.
15. The method of claim 14, wherein the model cornea is produced by measuring the corneas of a population.
16. The method of claim 15, wherein the aberration of the cornea is an average corneal aberration of the population.
17. The method of claim 15, wherein the population includes people of a specific age group, people with a cataract, people who have received a corneal ablative procedure, people who are candidates for a corneal ablative procedure, and/or people who are highly myopic or highly hyperopic.
18. The method of claim 10, further comprising selecting the spherical aberration of the intraocular lens to reduce the aberration of the cornea.
19. The method of claim 10, wherein measuring at least one surface of the cornea comprises characterizing at least a front corneal surface of an individual by means of a topographical measurement.
20. A method of performing visual correction in a patient by implanting an intraocular lens, comprising:
(i) determining a spherical aberration of a cornea of an individual patient;
(ii) based on the aberration of the cornea, providing an individualized lens that is tailored for the individual, the lens comprising a spherical aberration to reduce the spherical aberration of the cornea.
21. The method of claim 20, wherein determining the spherical aberration of the cornea comprises measuring at least one surface of the cornea.
22. The method of claim 20, further comprising performing a wavefront analysis of an aphakic eye.
23. The method of claim 20, wherein the spherical aberration of individualized lens balances the spherical aberration of the cornea.
US11/742,996 2000-05-23 2007-05-01 Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations Abandoned US20070258044A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/742,996 US20070258044A1 (en) 2000-05-23 2007-05-01 Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
SE0001925A SE0001925D0 (en) 2000-05-23 2000-05-23 Methods of obtaining ophthalmic lenses capable of reducing the aberrations of the eye
SE0001925-7 2000-05-23
US20773400P 2000-05-26 2000-05-26
SE0004830A SE0004830D0 (en) 2000-12-22 2000-12-22 An ophthalmic lens and a method for designing such a lens
SE0004830-6 2000-12-22
US25992401P 2001-01-05 2001-01-05
US09/863,546 US6609793B2 (en) 2000-05-23 2001-05-23 Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations
US10/606,910 US7241311B2 (en) 2000-05-23 2003-06-26 Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations
US11/742,996 US20070258044A1 (en) 2000-05-23 2007-05-01 Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/606,910 Continuation US7241311B2 (en) 2000-05-23 2003-06-26 Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations

Publications (1)

Publication Number Publication Date
US20070258044A1 true US20070258044A1 (en) 2007-11-08

Family

ID=27532716

Family Applications (5)

Application Number Title Priority Date Filing Date
US09/863,546 Expired - Lifetime US6609793B2 (en) 2000-05-23 2001-05-23 Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations
US10/606,910 Expired - Lifetime US7241311B2 (en) 2000-05-23 2003-06-26 Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations
US11/619,098 Abandoned US20070121064A1 (en) 2000-05-23 2007-01-02 Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations
US11/742,996 Abandoned US20070258044A1 (en) 2000-05-23 2007-05-01 Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations
US12/175,395 Expired - Fee Related US7841720B2 (en) 2000-05-23 2008-07-17 Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations

Family Applications Before (3)

Application Number Title Priority Date Filing Date
US09/863,546 Expired - Lifetime US6609793B2 (en) 2000-05-23 2001-05-23 Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations
US10/606,910 Expired - Lifetime US7241311B2 (en) 2000-05-23 2003-06-26 Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations
US11/619,098 Abandoned US20070121064A1 (en) 2000-05-23 2007-01-02 Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations

Family Applications After (1)

Application Number Title Priority Date Filing Date
US12/175,395 Expired - Fee Related US7841720B2 (en) 2000-05-23 2008-07-17 Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations

Country Status (1)

Country Link
US (5) US6609793B2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090006508A1 (en) * 2007-06-27 2009-01-01 Gerhard Youssefi Method and apparatus for extrapolating diagnostic data
US20100079725A1 (en) * 2008-09-30 2010-04-01 Davis Brett A Lens Design Simplification Process
US9463088B2 (en) 2011-04-05 2016-10-11 Kowa Company, Ltd. Intraocular lens design method and intraocular lens

Families Citing this family (183)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19938203A1 (en) * 1999-08-11 2001-02-15 Aesculap Meditec Gmbh Method and device for correcting visual defects in the human eye
CN101023860B (en) * 1999-10-21 2010-06-16 泰克诺拉斯眼科系统有限公司 Customized corneal profiling
US6609793B2 (en) * 2000-05-23 2003-08-26 Pharmacia Groningen Bv Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations
US8020995B2 (en) 2001-05-23 2011-09-20 Amo Groningen Bv Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations
IL137635A0 (en) * 2000-08-01 2001-10-31 Visionix Ltd Apparatus for interactive optometry
SE0004829D0 (en) * 2000-12-22 2000-12-22 Pharmacia Groningen Bv Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations
JP2004534964A (en) 2001-04-27 2004-11-18 ノバルティス アクチエンゲゼルシャフト Automatic lens design and manufacturing system
IL143503A0 (en) * 2001-05-31 2002-04-21 Visionix Ltd Aberration correction spectacle lens
US20030060878A1 (en) * 2001-08-31 2003-03-27 Shadduck John H. Intraocular lens system and method for power adjustment
JP3860041B2 (en) * 2002-01-23 2006-12-20 株式会社メニコン Contact lens and contact lens design method
US7261737B2 (en) * 2002-12-12 2007-08-28 Powervision, Inc. Accommodating intraocular lens system and method
US8048155B2 (en) 2002-02-02 2011-11-01 Powervision, Inc. Intraocular implant devices
US20040021826A1 (en) * 2002-08-01 2004-02-05 Sarver Edwin J. Combination advanced corneal topography/wave front aberration measurement
US7381221B2 (en) * 2002-11-08 2008-06-03 Advanced Medical Optics, Inc. Multi-zonal monofocal intraocular lens for correcting optical aberrations
US7209414B2 (en) * 2002-11-15 2007-04-24 Plasmon Lms, Inc Spherical aberration compensation by wavelength
US7896916B2 (en) * 2002-11-29 2011-03-01 Amo Groningen B.V. Multifocal ophthalmic lens
SE0203564D0 (en) 2002-11-29 2002-11-29 Pharmacia Groningen Bv Multifocal opthalmic lens
US7662180B2 (en) 2002-12-05 2010-02-16 Abbott Medical Optics Inc. Accommodating intraocular lens and method of manufacture thereof
US8328869B2 (en) 2002-12-12 2012-12-11 Powervision, Inc. Accommodating intraocular lenses and methods of use
US8361145B2 (en) * 2002-12-12 2013-01-29 Powervision, Inc. Accommodating intraocular lens system having circumferential haptic support and method
US7217288B2 (en) 2002-12-12 2007-05-15 Powervision, Inc. Accommodating intraocular lens having peripherally actuated deflectable surface and method
US10835373B2 (en) 2002-12-12 2020-11-17 Alcon Inc. Accommodating intraocular lenses and methods of use
US7036931B2 (en) * 2003-01-29 2006-05-02 Novartis Ag Ophthalmic lenses
GB0303193D0 (en) * 2003-02-12 2003-03-19 Guillon Michael Methods & lens
WO2004081613A2 (en) 2003-03-06 2004-09-23 Shadduck John H Adaptive optic lens and method of making
US7703919B2 (en) * 2003-03-28 2010-04-27 Digital Vision, Llc Application of neuro-ocular wavefront data in vision correction
WO2004090611A2 (en) * 2003-03-31 2004-10-21 Bausch & Lomb Incorporated Intraocular lens and method for reducing aberrations in an ocular system
US7905917B2 (en) * 2003-03-31 2011-03-15 Bausch & Lomb Incorporated Aspheric lenses and lens family
US7556378B1 (en) * 2003-04-10 2009-07-07 Tsontcho Ianchulev Intraoperative estimation of intraocular lens power
DE10325841A1 (en) * 2003-06-06 2004-12-30 Acritec Gmbh intraocular lens
JP4842835B2 (en) * 2003-12-09 2011-12-21 アボット・メディカル・オプティクス・インコーポレイテッド Foldable intraocular lens and manufacturing method thereof
US7615073B2 (en) * 2003-12-09 2009-11-10 Advanced Medical Optics, Inc. Foldable intraocular lens and method of making
DE102004009212B4 (en) * 2004-02-25 2015-08-20 Carl Zeiss Meditec Ag Contact element for laser processing and laser processing device
US7476248B2 (en) * 2004-04-06 2009-01-13 Alcon, Inc. Method of calculating the required lens power for an opthalmic implant
AU2005234778B2 (en) 2004-04-20 2011-04-21 Alcon Inc. Integrated surgical microscope and wavefront sensor
US9872763B2 (en) 2004-10-22 2018-01-23 Powervision, Inc. Accommodating intraocular lenses
US7922326B2 (en) 2005-10-25 2011-04-12 Abbott Medical Optics Inc. Ophthalmic lens with multiple phase plates
AU2005299605C1 (en) * 2004-10-25 2012-02-16 Johnson & Johnson Surgical Vision, Inc. Ophthalmic lens with multiple phase plates
SE0402769D0 (en) * 2004-11-12 2004-11-12 Amo Groningen Bv Method of selecting intraocular lenses
ITTO20040825A1 (en) * 2004-11-23 2005-02-23 Cogliati Alvaro ARTIFICIAL LENSES IN PARTICULAR CONTACT LENSES OR INTRA-OCULAR LENSES FOR THE CORRECTION OF THE PRESBYOPIA EVENTUALLY ASSOCIATED WITH OTHER VISUAL DEFECTS, AND THEIR MANUFACTURING METHOD
US20060116764A1 (en) * 2004-12-01 2006-06-01 Simpson Michael J Apodized aspheric diffractive lenses
US20060116763A1 (en) * 2004-12-01 2006-06-01 Simpson Michael J Contrast-enhancing aspheric intraocular lens
US7325927B2 (en) * 2005-01-11 2008-02-05 The University Of Houston Method of filtering data for the objective classification of eyes
US7537344B2 (en) * 2005-03-09 2009-05-26 Advanced Vision Engineering, Inc Methods for specifying image quality of human eyes from wavefront measurements
MXPA06014056A (en) * 2005-04-05 2007-03-07 Alcon Inc Optimal iol shape factors for human eyes.
NL1029037C2 (en) * 2005-05-13 2006-11-14 Akkolens Int Bv Artificial intraocular lens with variable optical strength, comprises optical elements with different shapes
US7261412B2 (en) 2005-06-30 2007-08-28 Visx, Incorporated Presbyopia correction through negative high-order spherical aberration
US7668342B2 (en) 2005-09-09 2010-02-23 Carl Zeiss Meditec, Inc. Method of bioimage data processing for revealing more meaningful anatomic features of diseased tissues
US8801781B2 (en) * 2005-10-26 2014-08-12 Abbott Medical Optics Inc. Intraocular lens for correcting corneal coma
EP2041615A4 (en) * 2005-11-09 2011-03-09 Univ Houston Method for designing and manufacturing custom optics
US8474974B2 (en) * 2006-02-24 2013-07-02 Amo Development Llc. Induced high order aberrations corresponding to geometrical transformations
US7695136B2 (en) * 2007-08-01 2010-04-13 Amo Development, Llc. Wavefront refractions and high order aberration correction when wavefront maps involve geometrical transformations
US8454160B2 (en) 2006-02-24 2013-06-04 Amo Development, Llc Zone extension systems and methods
US7717562B2 (en) 2006-02-24 2010-05-18 Amo Development Llc. Scaling Zernike coefficients to smaller pupil sizes for refractive treatments
JP5313699B2 (en) * 2006-03-08 2013-10-09 サイエンティフィック オプティクス, インク. Method and apparatus for universal improvement of visual acuity
US7768652B2 (en) 2006-03-16 2010-08-03 Carl Zeiss Meditec, Inc. Methods for mapping tissue with optical coherence tomography data
US7780294B2 (en) * 2006-03-23 2010-08-24 Amo Manufacturing Usa, Llc. Systems and methods for wavefront reconstruction for aperture with arbitrary shape
DE102006021521A1 (en) * 2006-05-05 2007-11-08 Carl Zeiss Meditec Ag Aspherical artificial eye lens and method for the construction of such
US7879089B2 (en) 2006-05-17 2011-02-01 Alcon, Inc. Correction of higher order aberrations in intraocular lenses
US20080004698A1 (en) * 2006-06-30 2008-01-03 Alcon, Inc. Correction of surgically-induced astigmatism during intraocular lens implants
WO2008008731A2 (en) 2006-07-10 2008-01-17 Amo Manufacturing Usa, Llc Systems and methods for wavefront analysis over circular and noncircular pupils
AR062067A1 (en) 2006-07-17 2008-10-15 Novartis Ag TORICAS CONTACT LENSES WITH CONTROLLED OPTICAL POWER PROFILE
ATE524139T1 (en) * 2006-12-13 2011-09-15 Akkolens Int Bv ACCOMMODATION INTRAOCULAR LENS WITH VARIABLE CORRECTION
FR2910645B1 (en) * 2006-12-22 2009-07-03 Essilor Int METHOD FOR DETERMINING AN OPHTHALMIC LENS
ES2313837B1 (en) * 2007-05-07 2009-12-17 Consejo Superior De Investigaciones Cientificas ANALYTICAL DESIGN OF INTRAOCULAR LENSES.
US8314927B2 (en) * 2007-07-23 2012-11-20 Powervision, Inc. Systems and methods for testing intraocular lenses
AU2008279173B2 (en) 2007-07-23 2014-07-31 Alcon Inc. Lens delivery system
JP5752415B2 (en) 2007-07-23 2015-07-22 パワーヴィジョン・インコーポレーテッド Correction of the refractive power of the lens after implantation
US8968396B2 (en) 2007-07-23 2015-03-03 Powervision, Inc. Intraocular lens delivery systems and methods of use
JP5346022B2 (en) 2007-07-23 2013-11-20 パワーヴィジョン・インコーポレーテッド Accommodating intraocular lens and method of use
US8747466B2 (en) * 2007-08-27 2014-06-10 Amo Groningen, B.V. Intraocular lens having extended depth of focus
US20090062911A1 (en) * 2007-08-27 2009-03-05 Amo Groningen Bv Multizonal lens with extended depth of focus
US9216080B2 (en) * 2007-08-27 2015-12-22 Amo Groningen B.V. Toric lens with decreased sensitivity to cylinder power and rotation and method of using the same
US8974526B2 (en) 2007-08-27 2015-03-10 Amo Groningen B.V. Multizonal lens with extended depth of focus
US8740978B2 (en) * 2007-08-27 2014-06-03 Amo Regional Holdings Intraocular lens having extended depth of focus
US7594729B2 (en) 2007-10-31 2009-09-29 Wf Systems, Llc Wavefront sensor
US7654672B2 (en) * 2007-10-31 2010-02-02 Abbott Medical Optics Inc. Systems and software for wavefront data processing, vision correction, and other applications
WO2009076500A1 (en) * 2007-12-11 2009-06-18 Bausch & Lomb Incorporated Method and apparatus for providing eye optical systems with extended depths of field
US9724190B2 (en) * 2007-12-13 2017-08-08 Amo Groningen B.V. Customized multifocal ophthalmic lens
US7878651B2 (en) * 2007-12-26 2011-02-01 Carl Zeiss Meditec, Inc. Refractive prescription using optical coherence tomography
AU2009214036B2 (en) * 2008-02-15 2014-04-17 Amo Regional Holdings System, ophthalmic lens, and method for extending depth of focus
US8439498B2 (en) 2008-02-21 2013-05-14 Abbott Medical Optics Inc. Toric intraocular lens with modified power characteristics
US8034108B2 (en) 2008-03-28 2011-10-11 Abbott Medical Optics Inc. Intraocular lens having a haptic that includes a cap
WO2010064150A2 (en) * 2008-04-04 2010-06-10 Amo Regional Holdings Systems and methods for determing intraocular lens power
KR101572634B1 (en) 2008-04-04 2015-12-01 포사이트 비젼4, 인크. Therapeutic device for pain management and vision
US7871162B2 (en) * 2008-04-24 2011-01-18 Amo Groningen B.V. Diffractive multifocal lens having radially varying light distribution
US8231219B2 (en) * 2008-04-24 2012-07-31 Amo Groningen B.V. Diffractive lens exhibiting enhanced optical performance
US8862447B2 (en) 2010-04-30 2014-10-14 Amo Groningen B.V. Apparatus, system and method for predictive modeling to design, evaluate and optimize ophthalmic lenses
US20100079723A1 (en) * 2008-10-01 2010-04-01 Kingston Amanda C Toric Ophthalimc Lenses Having Selected Spherical Aberration Characteristics
ES2368103T3 (en) 2008-10-15 2011-11-14 Carl Zeiss Meditec France S.A.S. METHOD FOR MODELING AN INTRAOCULAR LENS AND INTRAOCULAR LENS.
US8771348B2 (en) * 2008-10-20 2014-07-08 Abbott Medical Optics Inc. Multifocal intraocular lens
US8292953B2 (en) 2008-10-20 2012-10-23 Amo Groningen B.V. Multifocal intraocular lens
US8734511B2 (en) * 2008-10-20 2014-05-27 Amo Groningen, B.V. Multifocal intraocular lens
US8550624B2 (en) 2008-11-06 2013-10-08 Wavetec Vision Systems, Inc. Optical angular measurement system for ophthalmic applications and method for positioning of a toric intraocular lens with increased accuracy
US10299913B2 (en) 2009-01-09 2019-05-28 Powervision, Inc. Accommodating intraocular lenses and methods of use
ES2634107T3 (en) 2009-03-04 2017-09-26 Perfect Ip, Llc System to form and modify lenses and lenses formed by it
US8292952B2 (en) * 2009-03-04 2012-10-23 Aaren Scientific Inc. System for forming and modifying lenses and lenses formed thereby
US8646916B2 (en) * 2009-03-04 2014-02-11 Perfect Ip, Llc System for characterizing a cornea and obtaining an opthalmic lens
CA2763037C (en) 2009-05-22 2019-04-02 Abbott Medical Optics Inc. Ophthalmic lenses with enhanced surface and methods of fabrication thereof
EP2445446B1 (en) 2009-06-26 2019-01-09 Johnson & Johnson Surgical Vision, Inc. Accommodating intraocular lenses
US8876290B2 (en) * 2009-07-06 2014-11-04 Wavetec Vision Systems, Inc. Objective quality metric for ocular wavefront measurements
ES2524618T3 (en) 2009-07-14 2014-12-10 Wavetec Vision Systems, Inc. Determination of the effective position of the lens of an intraocular lens using afractive refractive power
EP2453823B1 (en) 2009-07-14 2015-05-13 WaveTec Vision Systems, Inc. Ophthalmic surgery measurement system
US8343217B2 (en) 2009-08-03 2013-01-01 Abbott Medical Optics Inc. Intraocular lens and methods for providing accommodative vision
US8332016B2 (en) 2009-08-04 2012-12-11 Carl Zeiss Meditec, Inc. Non-linear projections of 3-D medical imaging data
WO2011025846A1 (en) * 2009-08-27 2011-03-03 Novartis Ag Optimizing optical aberrations in ophthalmic lenses
US8210683B2 (en) * 2009-08-27 2012-07-03 Virginia Mason Medical Center No-history method for intraocular lens power adjustment after excimer laser refractive surgery
WO2011026068A2 (en) * 2009-08-31 2011-03-03 Powervision, Inc. Lens capsule size estimation
EP2490620A4 (en) 2009-10-23 2017-03-22 Forsight Labs, Llc Conformable therapeutic shield for vision and pain
WO2011050327A1 (en) 2009-10-23 2011-04-28 Forsight Labs Llc Corneal denervation for treatment of ocular pain
US8591025B1 (en) 2012-09-11 2013-11-26 Nexisvision, Inc. Eye covering and refractive correction methods for LASIK and other applications
US8623083B2 (en) 2009-11-06 2014-01-07 Amo Groningen B.V. Diffractive binocular lens systems and methods
CN102892381A (en) 2009-12-18 2013-01-23 Amo格罗宁根私人有限公司 Single microstructure lens, systems and methods
US8331048B1 (en) 2009-12-18 2012-12-11 Bausch & Lomb Incorporated Methods of designing lenses having selected depths of field
US7828435B1 (en) 2010-02-03 2010-11-09 Denis Rehse Method for designing an anterior curve of a contact lens
EP3263574B1 (en) 2010-02-23 2019-04-03 PowerVision, Inc. Accomodating intraocular lens
US8256896B2 (en) 2010-02-25 2012-09-04 Abbott Medical Optic Inc. Toric optic for ophthalmic use
US8205987B2 (en) * 2010-04-20 2012-06-26 Carl Zeiss Vision Inc. Method for optimizing a spectacle lens for the wavefront aberrations of an eye and lens
ES2374916B1 (en) 2010-06-02 2013-01-30 Consejo Superior De Investigaciones Científicas (Csic) PROCEDURE FOR PREPARING AN ISOPLANTIC ASPHERIC ASPHERIC MONOFOCAL INTRAOCULAR LENS AND LENS OBTAINED USING THIS PROCEDURE.
WO2012006616A2 (en) 2010-07-09 2012-01-12 Powervision, Inc. Intraocular lens delivery devices and methods of use
US9395558B2 (en) 2010-10-25 2016-07-19 Nexisvision, Inc. Methods and apparatus to identify eye coverings for vision
WO2012074742A1 (en) 2010-11-30 2012-06-07 Amo Groningen Bv Method for designing, evaluating and optimizing ophthalmic lenses and laser vision correction
EP2646872A1 (en) 2010-12-01 2013-10-09 AMO Groningen B.V. A multifocal lens having an optical add power progression, and a system and method of providing same
US10456026B2 (en) 2010-12-15 2019-10-29 Amo Wavefront Sciences, Llc Apparatus, system, and method for intraocular lens power calculation using a regression formula incorporating corneal spherical aberration
US8623081B2 (en) 2010-12-15 2014-01-07 Amo Groningen B.V. Apparatus, system, and method for intraocular lens power calculation using a regression formula incorporating corneal spherical aberration
US8894204B2 (en) 2010-12-17 2014-11-25 Abbott Medical Optics Inc. Ophthalmic lens, systems and methods having at least one rotationally asymmetric diffractive structure
US9931200B2 (en) 2010-12-17 2018-04-03 Amo Groningen B.V. Ophthalmic devices, systems, and methods for optimizing peripheral vision
EP2689748B1 (en) 2011-03-24 2017-02-22 Kowa Company, Ltd. Intraocular lens and manufacturing method therefor
JP6071995B2 (en) 2011-03-24 2017-02-01 パワーヴィジョン・インコーポレーテッド Intraocular lens loading system and method of use
US8864306B2 (en) 2011-04-28 2014-10-21 Nexisvision, Inc. Eye covering and refractive correction methods and apparatus having improved tear flow, comfort, and/or applicability
US8678584B2 (en) 2012-04-20 2014-03-25 Nexisvision, Inc. Contact lenses for refractive correction
WO2014210186A2 (en) 2013-06-26 2014-12-31 Nexisvision, Inc. Contact lenses for refractive correction
US9226654B2 (en) 2011-04-29 2016-01-05 Carl Zeiss Meditec, Inc. Systems and methods for automated classification of abnormalities in optical coherence tomography images of the eye
US20150342728A1 (en) 2011-10-11 2015-12-03 Aleksey Nikolaevich Simonov Accomodating Intraocular Lens with Optical Correction Surfaces
CA2851975A1 (en) 2011-10-14 2013-04-18 Amo Groningen B.V. Apparatus, system and method to account for spherical aberration at the iris plane in the design of an intraocular lens
US10433949B2 (en) 2011-11-08 2019-10-08 Powervision, Inc. Accommodating intraocular lenses
TWI588560B (en) 2012-04-05 2017-06-21 布萊恩荷登視覺協會 Lenses, devices, methods and systems for refractive error
US9465233B2 (en) 2012-04-20 2016-10-11 Nexisvision, Inc. Bimodular contact lenses
CN104335104B (en) 2012-04-20 2017-06-09 内希斯视觉股份有限公司 For the contact lens of correction of refractive errors
US9084674B2 (en) 2012-05-02 2015-07-21 Abbott Medical Optics Inc. Intraocular lens with shape changing capability to provide enhanced accomodation and visual acuity
CN108013952A (en) 2012-08-31 2018-05-11 Amo格罗宁根私人有限公司 Polycyclic crystalline lens, system and method for extended focal depth
US9974646B2 (en) 2012-09-05 2018-05-22 University Of Miami Keratoprosthesis, and system and method of corneal repair using same
US9072462B2 (en) 2012-09-27 2015-07-07 Wavetec Vision Systems, Inc. Geometric optical power measurement device
FR2996161B1 (en) * 2012-09-28 2014-10-31 Essilor Int METHOD FOR MANUFACTURING AN OPHTHALMIC LENS
US9201250B2 (en) 2012-10-17 2015-12-01 Brien Holden Vision Institute Lenses, devices, methods and systems for refractive error
TWI600418B (en) 2012-10-17 2017-10-01 布萊恩荷登視覺協會 Lenses, devices, methods and systems for refractive error
US9717628B2 (en) 2012-12-04 2017-08-01 Amo Groningen B.V. Lenses, systems and methods for providing binocular customized treatments to correct presbyopia
EP2967312B1 (en) 2013-03-11 2019-04-24 Johnson & Johnson Surgical Vision, Inc. Intraocular lens that matches an image surface to a retinal shape, and method of designing same
US20140330375A1 (en) * 2013-03-11 2014-11-06 Sean J. McCafferty Accommodating intraocular lens system with mutually-deforming opposing surfaces
ES2834479T3 (en) 2013-03-15 2021-06-17 Alcon Inc Method of reconfiguring an intraocular lens for delivery to a delivery device
CN203208162U (en) * 2013-04-22 2013-09-25 爱博诺德(北京)医疗科技有限公司 Aspherical intraocular lens
US9341864B2 (en) 2013-11-15 2016-05-17 Nexisvision, Inc. Contact lenses having a reinforcing scaffold
WO2015116559A1 (en) 2014-01-29 2015-08-06 Nexisvision, Inc. Multifocal bimodulus contact lenses
WO2015134058A1 (en) * 2014-03-07 2015-09-11 Mccafferty Sean Refocusable lens system with mutually-applanating internal surfaces
AU2015242298B2 (en) 2014-03-10 2019-11-14 Amo Groningen B.V. Intraocular lens that improves overall vision where there is a local loss of retinal function
US10010407B2 (en) 2014-04-21 2018-07-03 Amo Groningen B.V. Ophthalmic devices that improve peripheral vision
BR112017004765B1 (en) 2014-09-09 2022-08-23 Staar Surgical Company LENS CONFIGURED FOR IMPLANTATION IN A HUMAN EYE
WO2020086603A1 (en) * 2018-10-22 2020-04-30 Dynaoptics, Inc. Lens systems using free form elements to match object space and image space, and methods therefor
EP3884905A1 (en) 2015-11-06 2021-09-29 Alcon Inc. Ccommodating intraocular lenses
EP3413839A1 (en) 2016-02-09 2018-12-19 AMO Groningen B.V. Progressive power intraocular lens, and methods of use and manufacture
WO2017156077A1 (en) 2016-03-09 2017-09-14 Staar Surgical Company Ophthalmic implants with extended depth of field and enhanced distance visual acuity
WO2017153843A1 (en) 2016-03-11 2017-09-14 Amo Groningen B.V. Intraocular lenses that improve peripheral vision
EP3656350B1 (en) 2016-03-23 2021-06-23 Johnson & Johnson Surgical Vision, Inc. Ophthalmic apparatus with corrective meridians having extended tolerance band by modifying refractive powers in uniform meridian distribution
EP3932368A1 (en) 2016-03-23 2022-01-05 Johnson & Johnson Surgical Vision, Inc. Ophthalmic apparatus with corrective meridians having extended tolerance band
WO2017180914A1 (en) 2016-04-13 2017-10-19 Amo Wavefront Sciences, Llc Apparatus, system, and method for intraocular lens power calculation using a regression formula incorporating corneal spherical aberration
AU2017252020B2 (en) 2016-04-19 2021-11-11 Amo Groningen B.V. Ophthalmic devices, system and methods that improve peripheral vision
WO2018037356A1 (en) 2016-08-23 2018-03-01 Medicem Ophthalmic (Cy) Limited Ophthalmic lenses with aspheric optical surfaces and method for their manufacture
EP3522771B1 (en) 2016-10-25 2022-04-06 Amo Groningen B.V. Realistic eye models to design and evaluate intraocular lenses for a large field of view
EP3595584A1 (en) 2017-03-17 2020-01-22 AMO Groningen B.V. Diffractive intraocular lenses for extended range of vision
US10739227B2 (en) 2017-03-23 2020-08-11 Johnson & Johnson Surgical Vision, Inc. Methods and systems for measuring image quality
US11523897B2 (en) 2017-06-23 2022-12-13 Amo Groningen B.V. Intraocular lenses for presbyopia treatment
WO2019002390A1 (en) 2017-06-28 2019-01-03 Amo Groningen B.V. Extended range and related intraocular lenses for presbyopia treatment
EP3646110A1 (en) 2017-06-28 2020-05-06 Amo Groningen B.V. Diffractive lenses and related intraocular lenses for presbyopia treatment
US11327210B2 (en) 2017-06-30 2022-05-10 Amo Groningen B.V. Non-repeating echelettes and related intraocular lenses for presbyopia treatment
WO2019048707A1 (en) 2017-09-11 2019-03-14 Amo Groningen B.V. Intraocular lenses with customized add power
WO2019106067A1 (en) 2017-11-30 2019-06-06 Amo Groningen B.V. Intraocular lenses that improve post-surgical spectacle independent and methods of manufacturing thereof
US10895517B2 (en) 2018-02-08 2021-01-19 Amo Groningen B.V. Multi-wavelength wavefront system and method for measuring diffractive lenses
EP3749941A1 (en) 2018-02-08 2020-12-16 AMO Groningen B.V. Wavefront based characterization of lens surfaces based on reflections
CN112867944A (en) 2018-08-17 2021-05-28 斯塔尔外科有限公司 Polymer compositions exhibiting a refractive index nano-gradient
BR112022005512A2 (en) 2019-10-04 2022-06-14 Alcon Inc Adjustable intraocular lenses and post-operative intraocular lens adjustment methods
WO2021136617A1 (en) 2019-12-30 2021-07-08 Amo Groningen B.V. Lenses having diffractive profiles with irregular width for vision treatment
US11886046B2 (en) 2019-12-30 2024-01-30 Amo Groningen B.V. Multi-region refractive lenses for vision treatment
CN114326149B (en) * 2022-02-15 2022-09-30 天津大学 Spectacle lens structure and design method thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4504982A (en) * 1982-08-05 1985-03-19 Optical Radiation Corporation Aspheric intraocular lens
US5766016A (en) * 1994-11-14 1998-06-16 Georgia Tech Research Corporation Surgical simulator and method for simulating surgical procedure
US6305802B1 (en) * 1999-08-11 2001-10-23 Johnson & Johnson Vision Products, Inc. System and method of integrating corneal topographic data and ocular wavefront data with primary ametropia measurements to create a soft contact lens design
US6419359B2 (en) * 2000-04-11 2002-07-16 James Alan Edwards Surface design method

Family Cites Families (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1805561C3 (en) * 1967-10-30 1980-10-23 Societe Des Lunetiers, Paris Ophthalmic lens with strong refractive power and predetermined astigmatism
US3950082A (en) * 1973-01-10 1976-04-13 David Volk Ophthalmic lens for presbyopia and aphakia
US4055379A (en) * 1973-08-16 1977-10-25 American Optical Corporation Multifocal lens
US3960442A (en) * 1974-08-05 1976-06-01 American Optical Corporation Ophthalmic lens series
US4190621A (en) * 1977-03-10 1980-02-26 Martin Greshes Method for molding optical plastic lenses of the standard and bifocal type
US4268133A (en) * 1978-07-14 1981-05-19 Bausch & Lomb Incorporated Preferential orientation of contact lenses
US4322135A (en) * 1978-11-29 1982-03-30 Pilkington P. E. Limited Optical apparatus
US4310225A (en) * 1979-08-06 1982-01-12 Gentex Corporation Ophthalmic lens series
US4522194A (en) * 1983-02-18 1985-06-11 Baylor College Of Medicine Method and an apparatus for intra-aortic balloon monitoring and leak detection
US4580882A (en) * 1983-04-21 1986-04-08 Benjamin Nuchman Continuously variable contact lens
US4512039A (en) * 1983-05-24 1985-04-23 Lieberman David M Method of offsetting postoperative astigmatism with an intraocular lens
US4640595A (en) * 1984-05-02 1987-02-03 David Volk Aspheric contact lens
US4710193A (en) * 1986-08-18 1987-12-01 David Volk Accommodating intraocular lens and lens series and method of lens selection
US5236970A (en) 1987-02-05 1993-08-17 Allergan, Inc. Optically clear reinforced silicone elastomers of high optical refractive index and improved mechanical properties for use in intraocular lenses
US6007747A (en) 1987-08-24 1999-12-28 Pharmacia & Upjohn Company Method of making an aspheric soft lens
EP0308077A3 (en) * 1987-09-14 1990-05-30 Nestle S.A. Synthetic intracorneal lens
US5009497A (en) * 1987-11-12 1991-04-23 Cohen Allen L Contact lenses utilizing keel orientation
WO1989007303A1 (en) * 1988-02-03 1989-08-10 Steve Newman Improved contact lens design
US4859261A (en) * 1988-05-11 1989-08-22 Ace Ronald S Method of making multi-focus ophthalmic lens
US5050981A (en) 1990-07-24 1991-09-24 Johnson & Johnson Vision Products, Inc. Lens design method and resulting aspheric lens
US5125729A (en) * 1991-05-03 1992-06-30 Les Laboratoires Opti-Centre Inc. Multifocal contact lens
EP0597994A4 (en) * 1991-08-09 1994-09-14 Capricornia Contact Lens Toric lens with axis mislocation latitude.
US5786883A (en) * 1991-11-12 1998-07-28 Pilkington Barnes Hind, Inc. Annular mask contact lenses
US5444106A (en) 1992-04-21 1995-08-22 Kabi Pharmacia Ophthalmics, Inc. High refractive index silicone compositions
TW210380B (en) * 1992-04-23 1993-08-01 Ciba Geigy Ag
US5282852A (en) * 1992-09-02 1994-02-01 Alcon Surgical, Inc. Method of calculating the required power of an intraocular lens
US5760871A (en) * 1993-01-06 1998-06-02 Holo-Or Ltd. Diffractive multi-focal lens
US5771088A (en) * 1993-03-27 1998-06-23 Pilkington Barnes Hind, Inc. Contact lens designed to accommodate and correct for the effects of presbyopia
DE4403326C1 (en) * 1994-02-03 1995-06-22 Hans Reinhard Prof Dr Koch Intraocular lens arrangement for astigmatism correction
US20030060880A1 (en) * 1994-04-08 2003-03-27 Vladimir Feingold Toric intraocular lens
US5507806A (en) * 1994-05-13 1996-04-16 Pharmacia Iovision, Inc. Multi-faceted intraocular lens
AU3735195A (en) * 1994-10-06 1996-05-02 Vladimir Feingold Intraocular contact lens and method of implantation
IL118065A0 (en) * 1995-05-04 1996-08-04 Johnson & Johnson Vision Prod Aspheric toric lens designs
IL117937A0 (en) * 1995-05-04 1996-08-04 Johnson & Johnson Vision Prod Combined multifocal toric lens designs
US5652638A (en) * 1995-05-04 1997-07-29 Johnson & Johnson Vision Products, Inc. Concentric annular ring lens designs for astigmatism
IL118064A0 (en) * 1995-05-04 1996-08-04 Johnson & Johnson Vision Prod Concentric annular ring lens designs for astigmatic presbyopes
SE9501714D0 (en) 1995-05-09 1995-05-09 Pharmacia Ab A method of selecting an intraocular lens to be implanted into an eye
AU6330696A (en) * 1995-06-06 1996-12-24 Scientific Optics, Inc. Asymmetric bifocal intraocular lens
US6280470B1 (en) * 1995-10-20 2001-08-28 Gholam A. Peyman Intrastromal corneal modification
US5715090A (en) * 1996-02-20 1998-02-03 Eastman Kodak Company Color corrected viewfinder including a negative power lens component having a diffractive surface
US5880809A (en) * 1996-12-30 1999-03-09 Scientific Optics, Inc. Contact lens
CN100399107C (en) * 1996-03-21 2008-07-02 索拉国际控股有限公司 Improved single vision lenses
US5817130A (en) * 1996-05-03 1998-10-06 Sulzer Intermedics Inc. Implantable cardiac cardioverter/defibrillator with EMI suppression filter with independent ground connection
ES2206732T3 (en) * 1996-07-05 2004-05-16 Rodenstock Gmbh GLASS FOR PROGRESSIVE EFFECT GLASSES.
JPH1078566A (en) * 1996-09-05 1998-03-24 Asahi Optical Co Ltd Spectacle lens
JPH10175148A (en) * 1996-10-14 1998-06-30 Nikon Corp Base material for plastic lens and manufacturing device and method therefor
US5754270A (en) * 1996-11-08 1998-05-19 Unilens Corp., Usa Multifocal lens utilizing rapid power shift transition zone
US5777719A (en) * 1996-12-23 1998-07-07 University Of Rochester Method and apparatus for improving vision and the resolution of retinal images
ES2178159T3 (en) 1997-01-21 2002-12-16 Technomed Ges Fur Med Und Med PROCEDURE FOR THE CALCULATION OF A THEORETICAL FORM OF AT LEAST ONE SURFACE OF AN ARTIFICIAL OR NATURAL PART OF AN EYE CUTTED BY A BEAM BEAMING THROUGH THE PUPILA OF AN EYE, AND DEVICE FOR THE MANUFACTURE OF AN ARTIFICIAL CRYSTAL.
ID20540A (en) * 1997-04-07 1999-01-07 Bausch & Lomb METHOD FOR UNTUYK IDENTIFY THE CHARACTERISTICS OF THE CONTACT LENS
US5963299A (en) * 1997-07-22 1999-10-05 Reyburn; Thomas P. Method and apparatus for measuring toric contact lens rotation
FR2769997B1 (en) * 1997-10-16 1999-12-31 Essilor Int MULTIFOCAL OPHTHALMIC LENS
US6089710A (en) * 1998-07-20 2000-07-18 Oracle Lens Manufacturing Corporation Single-vision ophthalmic lens series
US6260966B1 (en) * 1998-03-11 2001-07-17 Menicon Co. Ltd. Multifocal ocular lens
US6203156B1 (en) * 1998-03-31 2001-03-20 Johnson & Johnson Vision Care, Inc. Contact lenses bearing marks
JP4023902B2 (en) * 1998-04-10 2007-12-19 株式会社メニコン Toric multifocal lens
US6491721B2 (en) * 1998-04-15 2002-12-10 Alcon Manufacturing, Ltd. Toric intraocular lens material
US6416550B2 (en) * 1998-04-15 2002-07-09 Alcon Manufacturing, Ltd. Method of selecting an intraocular lens material
EP1103014A4 (en) * 1998-08-06 2006-09-06 John B W Lett Multifocal aspheric lens
FR2783938B1 (en) * 1998-09-28 2000-11-17 Essilor Int TORIC OPHTHALMIC LENSES
US7303281B2 (en) * 1998-10-07 2007-12-04 Tracey Technologies, Llc Method and device for determining refractive components and visual function of the eye for vision correction
US6082856A (en) * 1998-11-09 2000-07-04 Polyvue Technologies, Inc. Methods for designing and making contact lenses having aberration control and contact lenses made thereby
US6176578B1 (en) * 1998-12-09 2001-01-23 Johnson & Johnson Vision Care, Inc. Toric contact lenses
US6197058B1 (en) * 1999-03-22 2001-03-06 Valdemar Portney Corrective intraocular lens system and intraocular lenses and lens handling device therefor
US6616692B1 (en) * 1999-04-30 2003-09-09 Advanced Medical Optics, Inc. Intraocular lens combinations
US20060238702A1 (en) * 1999-04-30 2006-10-26 Advanced Medical Optics, Inc. Ophthalmic lens combinations
US6224211B1 (en) 1999-06-08 2001-05-01 Medjet, Inc. Super vision
US6050687A (en) 1999-06-11 2000-04-18 20/10 Perfect Vision Optische Geraete Gmbh Method and apparatus for measurement of the refractive properties of the human eye
US6176579B1 (en) * 1999-07-07 2001-01-23 Softfocal Co., Inc Bifocal contact lens with toric transition
US6106118A (en) * 1999-09-05 2000-08-22 Johnson & Johnson Vision Products, Inc. Progressive addition lenses
US6086204A (en) * 1999-09-20 2000-07-11 Magnante; Peter C. Methods and devices to design and fabricate surfaces on contact lenses and on corneal tissue that correct the eye's optical aberrations
US6428573B2 (en) * 2000-02-03 2002-08-06 Howard J. Barnett Intraocular multifocal lens construction
DE10006896A1 (en) * 2000-02-16 2001-08-30 Wavelight Laser Technologie Ag Production of an intraocular or optical contact lens a blank is produced mechanically and the surface profile material is removed by laser beams according to the calculated structure required to correct the vision
US6390623B1 (en) * 2000-03-29 2002-05-21 Johnson & Johnson Vision Care, Inc. Customized progressive addition lenses
US6413276B1 (en) * 2000-04-26 2002-07-02 Emmetropia, Inc. Modified intraocular lens and method of correcting optical aberrations therein
JP4126144B2 (en) 2000-05-11 2008-07-30 インターナショナル・ビジネス・マシーンズ・コーポレーション Charging system, intelligent battery, and charging method
US6413277B1 (en) * 2000-05-18 2002-07-02 Tobias H. Neuhann Method for intraocular lens insertion and apparatus
US6609793B2 (en) * 2000-05-23 2003-08-26 Pharmacia Groningen Bv Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations
US6655803B1 (en) * 2000-06-01 2003-12-02 Inray Ltd. Wavefront method for designing optical elements
US6454409B1 (en) 2000-08-15 2002-09-24 Johnson & Johnson Vision Care, Inc. Contact lenses
US6582076B1 (en) * 2000-08-30 2003-06-24 Johnson & Johnson Vision Care, Inc. Ophthalmic lenses useful in correcting astigmatism and presbyopia
US6595639B1 (en) * 2000-11-10 2003-07-22 Ocular Sciences, Inc. Junctionless ophthalmic lenses and methods for making same
SE0004829D0 (en) * 2000-12-22 2000-12-22 Pharmacia Groningen Bv Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations
AU2002240147A1 (en) * 2001-02-01 2002-08-12 Tekia, Inc. Two part "l"- or "s"-shaped phakic iol
US6455409B1 (en) * 2001-02-28 2002-09-24 Advanced Micro Devices, Inc. Damascene processing using a silicon carbide hard mask
US6709105B2 (en) * 2001-04-10 2004-03-23 Johnson & Johnson Vision Care, Inc. Progressive addition lenses
US6638305B2 (en) * 2001-05-15 2003-10-28 Advanced Medical Optics, Inc. Monofocal intraocular lens convertible to multifocal intraocular lens
JP2002350785A (en) 2001-05-28 2002-12-04 Menicon Co Ltd Method of designing ocular lens
US20030014107A1 (en) * 2001-06-28 2003-01-16 Michael Reynard Multifocal phakic intraocular lens
US6533416B1 (en) * 2001-07-20 2003-03-18 Ocular Sciences, Inc. Contact or intraocular lens and method for its preparation
US20030033011A1 (en) * 2001-08-08 2003-02-13 Singer Jack A. Intraocular lens for vision correction and cataract prevention
JP4110812B2 (en) 2002-03-28 2008-07-02 東レ株式会社 Materials that improve respiratory function
US6663240B2 (en) * 2002-05-15 2003-12-16 Alcon, Inc. Method of manufacturing customized intraocular lenses
MXPA06014056A (en) * 2005-04-05 2007-03-07 Alcon Inc Optimal iol shape factors for human eyes.

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4504982A (en) * 1982-08-05 1985-03-19 Optical Radiation Corporation Aspheric intraocular lens
US5766016A (en) * 1994-11-14 1998-06-16 Georgia Tech Research Corporation Surgical simulator and method for simulating surgical procedure
US6305802B1 (en) * 1999-08-11 2001-10-23 Johnson & Johnson Vision Products, Inc. System and method of integrating corneal topographic data and ocular wavefront data with primary ametropia measurements to create a soft contact lens design
US6419359B2 (en) * 2000-04-11 2002-07-16 James Alan Edwards Surface design method

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090006508A1 (en) * 2007-06-27 2009-01-01 Gerhard Youssefi Method and apparatus for extrapolating diagnostic data
US8740381B2 (en) * 2007-06-27 2014-06-03 Bausch & Lomb Incorporated Method and apparatus for extrapolating diagnostic data
US20100079725A1 (en) * 2008-09-30 2010-04-01 Davis Brett A Lens Design Simplification Process
US8272735B2 (en) * 2008-09-30 2012-09-25 Johnson & Johnson Vision Care, Inc. Lens design simplification process
US9463088B2 (en) 2011-04-05 2016-10-11 Kowa Company, Ltd. Intraocular lens design method and intraocular lens

Also Published As

Publication number Publication date
US20090036980A1 (en) 2009-02-05
US6609793B2 (en) 2003-08-26
US7841720B2 (en) 2010-11-30
US20070121064A1 (en) 2007-05-31
US20040088050A1 (en) 2004-05-06
US20020105617A1 (en) 2002-08-08
US7241311B2 (en) 2007-07-10

Similar Documents

Publication Publication Date Title
US7841720B2 (en) Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations
EP2332495B1 (en) Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations
US9504377B2 (en) Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations
US10085833B2 (en) Multifocal ophthalmic lens
US6705729B2 (en) Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations
AU2001263942A1 (en) Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations
US20060244905A1 (en) Multifocal ophthalmic lens
AU2002234579A1 (en) Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations
ZA200209763B (en) Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations.

Legal Events

Date Code Title Description
AS Assignment

Owner name: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT, NO

Free format text: INTELLECTUAL PROPERTY SECURITY AGREEMENT;ASSIGNOR:ADVANCED MEDICAL OPTICS, INC.;REEL/FRAME:019501/0069

Effective date: 20070402

Owner name: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT,NOR

Free format text: INTELLECTUAL PROPERTY SECURITY AGREEMENT;ASSIGNOR:ADVANCED MEDICAL OPTICS, INC.;REEL/FRAME:019501/0069

Effective date: 20070402

Owner name: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT, NORTH CAROLINA

Free format text: INTELLECTUAL PROPERTY SECURITY AGREEMENT;ASSIGNOR:ADVANCED MEDICAL OPTICS, INC.;REEL/FRAME:019501/0069

Effective date: 20070402

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION

AS Assignment

Owner name: ADVANCED MEDICAL OPTICS, INC., CALIFORNIA

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:BANK OF AMERICA, N.A. AS ADMINISTRATIVE AGENT;REEL/FRAME:022320/0427

Effective date: 20090225

Owner name: ADVANCED MEDICAL OPTICS, INC.,CALIFORNIA

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:BANK OF AMERICA, N.A. AS ADMINISTRATIVE AGENT;REEL/FRAME:022320/0427

Effective date: 20090225